{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:36:20Z","timestamp":1790742980012,"version":"4.1.0"},"publisher-location":"Cham","reference-count":331,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031667756","type":"print"},{"value":"9783031667763","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/164_2023_677","type":"book-chapter","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T20:02:00Z","timestamp":1690401720000},"page":"555-616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9944-8897","authenticated-orcid":false,"given":"Rachel A.","family":"Matt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3975-1480","authenticated-orcid":false,"given":"Renee S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2986-6476","authenticated-orcid":false,"given":"Andrew K.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9968-2299","authenticated-orcid":false,"given":"Joel R.","family":"Gever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8511-6042","authenticated-orcid":false,"given":"Gabriel A.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-1755","authenticated-orcid":false,"given":"Mehrdad","family":"Shamloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8618-0273","authenticated-orcid":false,"given":"Anthony P.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"677_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13073-017-0483-4","volume":"9","author":"H Abdelmotilib","year":"2017","unstructured":"Abdelmotilib H, West AB (2017) Breathing new life into an old target: pulmonary disease drugs for Parkinson\u2019s disease therapy. Genome Med 9:88","journal-title":"Genome Med"},{"key":"677_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1192\/bjp.135.3.216","volume":"135","author":"R Adolfsson","year":"1979","unstructured":"Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Brit J Psychiat 135:216\u2013223","journal-title":"Brit J Psychiat"},{"key":"677_CR3","first-page":"S21","volume":"176","author":"SPH Alexander","year":"2019","unstructured":"Alexander SPH et al (2019) THE CONCISE GUIDE TO PHARMACOLOGY 2019\/20: G protein-coupled receptors. Brit J Pharmacol 176:S21\u2013S141","journal-title":"Brit J Pharmacol"},{"key":"677_CR4","doi-asserted-by":"publisher","unstructured":"Altosaar K et al (2021) Adrenoceptors (version 2019.3) in the IUPHAR\/BPS guide to pharmacology database. https:\/\/doi.org\/10.2218\/gtopdb\/F4\/2021.3","DOI":"10.2218\/gtopdb\/F4\/2021.3"},{"key":"677_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","volume":"133","author":"A Anandhan","year":"2017","unstructured":"Anandhan A et al (2017) Metabolic dysfunction in Parkinson\u2019s disease: bioenergetics, redox homeostasis and central carbon metabolism. Brain Res Bull 133:12\u201330","journal-title":"Brain Res Bull"},{"key":"677_CR6","doi-asserted-by":"crossref","unstructured":"Andrade C (2018) How to read a research paper: an exercise in critical thinking in the context of an epidemiologic study on tamsulosin and the risk of dementia. J Clin Psychiatry 79","DOI":"10.4088\/JCP.18f12660"},{"key":"677_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/nan.12386","volume":"43","author":"P Andr\u00e9s-Benito","year":"2017","unstructured":"Andr\u00e9s-Benito P et al (2017) Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology. Neuropath Appl Neuro 43:373\u2013392","journal-title":"Neuropath Appl Neuro"},{"key":"677_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1126\/science.181.4100.682","volume":"181","author":"GM Anlezark","year":"1973","unstructured":"Anlezark GM, Crow TJ, Greenway AP (1973) Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesions. Science 181:682\u2013684","journal-title":"Science"},{"key":"677_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.neuropharm.2017.01.010","volume":"116","author":"PM Ardestani","year":"2017","unstructured":"Ardestani PM et al (2017) Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer\u2019s disease using a biased and selective beta-1 adrenergic receptor partial agonist. Neuropharmacology 116:371\u2013386","journal-title":"Neuropharmacology"},{"key":"677_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S1474-4422(16)30029-1","volume":"15","author":"Z Arvanitakis","year":"2016","unstructured":"Arvanitakis Z, Capuano AW, Leurgans SE, Bennett DA, Schneider JA (2016) Relation of cerebral vessel disease to Alzheimer\u2019s disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol 15:934\u2013943","journal-title":"Lancet Neurol"},{"key":"677_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40360-020-0394-7","volume":"21","author":"N Asano","year":"2020","unstructured":"Asano N, Hishiyama S, Ishiyama T, Kotoda M, Matsukawa T (2020) Effects of \u03b21-adrenergic receptor blockade on the cerebral microcirculation in the normal state and during global brain ischemia\/reperfusion injury in rabbits. BMC Pharmacol Toxicol 21:13","journal-title":"BMC Pharmacol Toxicol"},{"key":"677_CR12","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1523\/JNEUROSCI.14-07-04467.1994","volume":"14","author":"G Aston-Jones","year":"1994","unstructured":"Aston-Jones G, Rajkowski J, Kubiak P, Alexinsky T (1994) Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J Neurosci 14:4467\u20134480","journal-title":"J Neurosci"},{"key":"677_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0006-8993(73)90524-6","volume":"61","author":"P-F Aubineau","year":"1973","unstructured":"Aubineau P-F, Seylaz J, Sercombe R, Mamo H (1973) Evidence for regional differences in the effect of beta-adrenergic stimulation on cerebral blood flow. Brain Res 61:153\u2013161","journal-title":"Brain Res"},{"key":"677_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF01000158","volume":"7","author":"F Bacic","year":"1992","unstructured":"Bacic F, McCarron RM, Uematsu S, Spatz M (1992) Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endothelium. Metab Brain Dis 7:125\u2013137","journal-title":"Metab Brain Dis"},{"key":"677_CR15","first-page":"nonlin.003.01.0","volume":"3","author":"E Baldi","year":"2005","unstructured":"Baldi E, Bucherelli C (2005) The inverted \u201cU-shaped\u201d dose-effect relationships in learning and memory: modulation of arousal and consolidation. Dose-Response 3:nonlin.003.01.002","journal-title":"Dose-Response"},{"key":"677_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0028-3908(80)90187-2","volume":"19","author":"JM Baraban","year":"1980","unstructured":"Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355\u2013363","journal-title":"Neuropharmacology"},{"key":"677_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nbd.2015.10.006","volume":"85","author":"RT Bartus","year":"2016","unstructured":"Bartus RT et al (2016) \u03b22-adrenoceptor agonists as novel, safe and potentially effective therapies for amyotrophic lateral sclerosis (ALS). Neurobiol Dis 85:11\u201324","journal-title":"Neurobiol Dis"},{"key":"677_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/JAD-210191","volume":"83","author":"R Beardmore","year":"2021","unstructured":"Beardmore R, Hou R, Darekar A, Holmes C, Boche D (2021) The locus coeruleus in aging and Alzheimer\u2019s disease: a postmortem and brain imaging review. J Alzheimers Dis 83:5\u201322","journal-title":"J Alzheimers Dis"},{"key":"677_CR19","first-page":"108","volume":"21","author":"MA B\u00e9dard","year":"1998","unstructured":"B\u00e9dard MA et al (1998) Attentional deficits in Parkinson\u2019s disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist. Clin Neuropharmacol 21:108\u2013117","journal-title":"Clin Neuropharmacol"},{"key":"677_CR20","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/jcbfm.2012.115","volume":"32","author":"LK Bekar","year":"2012","unstructured":"Bekar LK, Wei HS, Nedergaard M (2012) The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand. J Cereb Blood Flow Metabolism 32:2135\u20132145","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","volume":"42","author":"CW Berridge","year":"2003","unstructured":"Berridge CW, Waterhouse BD (2003) The locus coeruleus\u2013noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42:33\u201384","journal-title":"Brain Res Rev"},{"key":"677_CR22","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1093\/brain\/awz193","volume":"142","author":"MJ Betts","year":"2019","unstructured":"Betts MJ et al (2019) Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain 142:2558\u20132571","journal-title":"Brain"},{"key":"677_CR23","volume-title":"Conference reports: international society for magnetic imaging in medicine","author":"C Bishop","year":"2022","unstructured":"Bishop C et al (2022a) Disentangling apparent discordance between ASL-MRI and [18F]-FDG PET following a single dose of the \u03b22-agonist clenbuterol. In: Conference reports: international society for magnetic imaging in medicine"},{"key":"677_CR24","volume-title":"Conference reports: international society for magnetic imaging in medicine","author":"C Bishop","year":"2022","unstructured":"Bishop C et al (2022b) Dose-dependent response of cerebral blood flow in healthy volunteers following administration of \u03b22-adrenergic receptor agonist clenbuterol. In: Conference reports: international society for magnetic imaging in medicine"},{"key":"677_CR25","unstructured":"Blier P (2001) Crosstalk between the norepinephrine and serotonin systems and its role in the antidepressant response. J Psychiatry Neurosci Jpn 26(Suppl):S3\u2013S10"},{"key":"677_CR26","doi-asserted-by":"publisher","unstructured":"Bolton CJ, Tam JW (2021) Differential involvement of the locus coeruleus in early- and late-onset Alzheimer\u2019s disease: a potential mechanism of clinical differences? J Geriatr Psych Neur:089198872110447. https:\/\/doi.org\/10.1177\/08919887211044755","DOI":"10.1177\/08919887211044755"},{"key":"677_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/00002093-198701040-00005","volume":"1","author":"W Bondareff","year":"1987","unstructured":"Bondareff W et al (1987a) Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord 1:256\u2013262","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"677_CR28","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/archpsyc.1987.01800170026005","volume":"44","author":"W Bondareff","year":"1987","unstructured":"Bondareff W et al (1987b) Age and histopathologic heterogeneity in Alzheimer\u2019s disease: evidence for subtypes. Arch Gen Psychiat 44:412\u2013417","journal-title":"Arch Gen Psychiat"},{"key":"677_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","volume":"19","author":"DR Borchelt","year":"1997","unstructured":"Borchelt DR et al (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939\u2013945","journal-title":"Neuron"},{"key":"677_CR30","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/npp.2016.18","volume":"41","author":"RJ Borchert","year":"2016","unstructured":"Borchert RJ et al (2016) Atomoxetine enhances connectivity of prefrontal networks in Parkinson\u2019s disease. Neuropsychopharmacology 41:2171\u20132177","journal-title":"Neuropsychopharmacology"},{"key":"677_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00429-010-0246-0","volume":"214","author":"P Borghammer","year":"2010","unstructured":"Borghammer P et al (2010) Cortical hypometabolism and hypoperfusion in Parkinson\u2019s disease is extensive: probably even at early disease stages. Brain Struct Funct 214:303\u2013317","journal-title":"Brain Struct Funct"},{"key":"677_CR32","doi-asserted-by":"publisher","first-page":"100284","DOI":"10.1016\/j.ynstr.2020.100284","volume":"13","author":"O Borodovitsyna","year":"2020","unstructured":"Borodovitsyna O, Duffy BC, Pickering AE, Chandler DJ (2020) Anatomically and functionally distinct locus coeruleus efferents mediate opposing effects on anxiety-like behavior. Neurobiology Stress 13:100284","journal-title":"Neurobiology Stress"},{"key":"677_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/jne.12002","volume":"25","author":"HN Boyda","year":"2013","unstructured":"Boyda HN, Procyshyn RM, Pang CCY, Barr AM (2013) Peripheral adrenoceptors: the impetus behind glucose dysregulation and insulin resistance. J Neuroendocrinol 25:217\u2013228","journal-title":"J Neuroendocrinol"},{"key":"677_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"677_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"677_CR36","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, R\u00fcb U, Steur ENHJ, Tredici KD, de Vos RAI (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"677_CR37","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Tredici KD (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960\u2013969","journal-title":"J Neuropathol Exp Neurol"},{"key":"677_CR38","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.neurobiolaging.2014.06.011","volume":"35","author":"C Branca","year":"2014","unstructured":"Branca C, Wisely EV, Hartman LK, Caccamo A, Oddo S (2014) Administration of a selective \u03b22 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging 35:2726\u20132735","journal-title":"Neurobiol Aging"},{"key":"677_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.autneu.2017.05.003","volume":"207","author":"P Brassard","year":"2017","unstructured":"Brassard P, Tymko MM, Ainslie PN (2017) Sympathetic control of the brain circulation: appreciating the complexities to better understand the controversy. Autonomic Neurosci 207:37\u201347","journal-title":"Autonomic Neurosci"},{"key":"677_CR40","doi-asserted-by":"publisher","first-page":"638007","DOI":"10.3389\/fncir.2021.638007","volume":"15","author":"V Breton-Provencher","year":"2021","unstructured":"Breton-Provencher V, Drummond GT, Sur M (2021) Locus coeruleus norepinephrine in learned behavior: anatomical modularity and spatiotemporal integration in targets. Front Neural Circuit 15:638007","journal-title":"Front Neural Circuit"},{"key":"677_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5414\/NPP30104","volume":"30","author":"H Brunnstr\u00f6m","year":"2011","unstructured":"Brunnstr\u00f6m H, Friberg N, Lindberg E, Englund E (2011) Differential degeneration of the locus coeruleus in dementia subtypes. Clin Neuropathol 30:104\u2013110","journal-title":"Clin Neuropathol"},{"key":"677_CR42","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.neurobiolaging.2003.10.006","volume":"25","author":"MJ Bullido","year":"2004","unstructured":"Bullido MJ et al (2004) Polymorphism in genes involved in adrenergic signaling associated with Alzheimer\u2019s. Neurobiol Aging 25:853\u2013859","journal-title":"Neurobiol Aging"},{"key":"677_CR43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1001\/archpsyc.1965.01730060001001","volume":"13","author":"WE Bunney","year":"1965","unstructured":"Bunney WE, Davis JM (1965) Norepinephrine in depressive reactions: a review. Arch Gen Psychiat 13:483\u2013494","journal-title":"Arch Gen Psychiat"},{"key":"677_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00004647-199701000-00009","volume":"17","author":"RB Buxton","year":"1996","unstructured":"Buxton RB, Frank LR (1996) A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation. J Cereb Blood Flow Metabolism 17:64\u201372","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR45","first-page":"121","volume":"46","author":"DB Bylund","year":"1994","unstructured":"Bylund DB et al (1994) International Union of pharmacology nomenclature of adrenoceptors. Pharmacology Reviews 46:121\u2013136","journal-title":"Pharmacology Reviews"},{"key":"677_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.2042-7158.1984.tb06941.x","volume":"36","author":"S Caccia","year":"1984","unstructured":"Caccia S, Fong MH (1984) Kinetics and distribution of the \u03b2-adrenergic agonist salbutamol in rat brain. J Pharm Pharmacol 36:200\u2013202","journal-title":"J Pharm Pharmacol"},{"key":"677_CR47","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI129987","volume":"129","author":"R Cai","year":"2019","unstructured":"Cai R et al (2019) Enhancing glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases. J Clin Invest 129:4539\u20134549","journal-title":"J Clin Invest"},{"key":"677_CR48","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola S, Mattson MP (2017) Brain metabolism in health, aging, and neurodegeneration. EMBO J 36:1474\u20131492","journal-title":"EMBO J"},{"key":"677_CR49","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3233\/JAD-210116","volume":"81","author":"A Camargo","year":"2021","unstructured":"Camargo A, Wang Z, Initiative ADN (2021) Longitudinal cerebral blood flow changes in normal aging and the Alzheimer\u2019s disease continuum identified by arterial spin labeling MRI. J Alzheimers Dis 81:1727\u20131735","journal-title":"J Alzheimers Dis"},{"key":"677_CR50","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/nn.2682","volume":"13","author":"ME Carter","year":"2010","unstructured":"Carter ME et al (2010) Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci 13:1526\u20131533","journal-title":"Nat Neurosci"},{"key":"677_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0006-8993(86)91112-1","volume":"370","author":"R Cash","year":"1986","unstructured":"Cash R, Raisman R, Lanfumey L, Ploska A, Agid Y (1986) Cellular localization of adrenergic receptors in rat and human brain. Brain Res 370:127\u2013135","journal-title":"Brain Res"},{"key":"677_CR52","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuroscience.2016.06.037","volume":"332","author":"MP Castelli","year":"2016","unstructured":"Castelli MP et al (2016) \u03b12A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons. Neuroscience 332:130\u2013139","journal-title":"Neuroscience"},{"key":"677_CR53","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/j.1476-5381.2010.01153.x","volume":"162","author":"SL Catus","year":"2011","unstructured":"Catus SL, Gibbs ME, Sato M, Summers RJ, Hutchinson DS (2011) Role of \u03b2-adrenoceptors in glucose uptake in astrocytes using \u03b2-adrenoceptor knockout mice. Brit J Pharmacol 162:1700\u20131715","journal-title":"Brit J Pharmacol"},{"key":"677_CR54","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s40261-019-00830-4","volume":"39","author":"MS Cepeda","year":"2019","unstructured":"Cepeda MS, Kern DM, Seabrook GR, Lovestone S (2019) Comprehensive real-world assessment of marketed medications to guide Parkinson\u2019s drug discovery. Clin Drug Invest 39:1067\u20131075","journal-title":"Clin Drug Invest"},{"key":"677_CR55","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.4103\/1673-5374.193241","volume":"11","author":"G Chai","year":"2016","unstructured":"Chai G, Wang Y, Yasheng A, Zhao P (2016) Beta 2-adrenergic receptor activation enhances neurogenesis in Alzheimer\u2019s disease mice. Neural Regen Res 11:1617\u20131624","journal-title":"Neural Regen Res"},{"key":"677_CR56","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neulet.2016.11.022","volume":"636","author":"G Chai","year":"2017","unstructured":"Chai G, Wang Y, Zhu D, Yasheng A, Zhao P (2017) Activation of \u03b22-adrenergic receptor promotes dendrite ramification and spine generation in APP\/PS1 mice. Neurosci Lett 636:158\u2013164","journal-title":"Neurosci Lett"},{"key":"677_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/alzrt175","volume":"5","author":"T Chalermpalanupap","year":"2013","unstructured":"Chalermpalanupap T et al (2013) Targeting norepinephrine in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Res Ther 5:21","journal-title":"Alzheimers Res Ther"},{"key":"677_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/7829507","volume":"2017","author":"T Chalermpalanupap","year":"2017","unstructured":"Chalermpalanupap T, Weinshenker D, Rorabaugh JM (2017) Down but not out: the consequences of pretangle tau in the locus coeruleus. Neural Plast 2017:1\u20139","journal-title":"Neural Plast"},{"key":"677_CR59","doi-asserted-by":"publisher","unstructured":"Chalermpalanupap T et al (2018) Locus coeruleus ablation exacerbates cognitive deficits, neuropathology, and lethality in P301S tau transgenic mice. J Neurosci:1483\u20131417. https:\/\/doi.org\/10.1523\/jneurosci.1483-17.2017","DOI":"10.1523\/jneurosci.1483-17.2017"},{"key":"677_CR60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/cne.902870308","volume":"287","author":"V Chan-Palay","year":"1989","unstructured":"Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression. J Comp Neurol 287:373\u2013392","journal-title":"J Comp Neurol"},{"key":"677_CR61","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1177\/0300060518781382","volume":"46","author":"J Cheng","year":"2018","unstructured":"Cheng J et al (2018) Dexmedetomidine attenuates cerebral ischemia\/reperfusion injury in neonatal rats by inhibiting TLR4 signaling. J Int Medical Res 46:2925\u20132932","journal-title":"J Int Medical Res"},{"key":"677_CR62","doi-asserted-by":"publisher","first-page":"e1006392","DOI":"10.1371\/journal.pcbi.1006392","volume":"14","author":"JS Coggan","year":"2018","unstructured":"Coggan JS et al (2018) Norepinephrine stimulates glycogenolysis in astrocytes to fuel neurons with lactate. PLoS Comput Biol 14:e1006392","journal-title":"PLoS Comput Biol"},{"key":"677_CR63","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/00004647-199708000-00008","volume":"17","author":"Z Cohen","year":"1997","unstructured":"Cohen Z, Molinatti G, Hamel E (1997) Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J Cereb Blood Flow Metabolism 17:894\u2013904","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR64","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1042\/bst0180541","volume":"18","author":"S Collins","year":"1990","unstructured":"Collins S et al (1990) Mechanisms involved in adrenergic receptor desensitization. Biochem Soc T 18:541\u2013544","journal-title":"Biochem Soc T"},{"key":"677_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00001756-199512000-00043","volume":"7","author":"DM Compton","year":"1995","unstructured":"Compton DM, Dietrich KL, Smith JS, Davis BK (1995) Spatial and non-spatial learning in the rat following lesions to the nucleus locus coeruleus. Neuroreport 7:177\u2013182","journal-title":"Neuroreport"},{"key":"677_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nlm.2019.02.009","volume":"161","author":"ZA Cope","year":"2019","unstructured":"Cope ZA, Vazey EM, Floresco SB, Jones GSA (2019) DREADD-mediated modulation of locus coeruleus inputs to mPFC improves strategy set-shifting. Neurobiol Learn Mem 161:1\u201311","journal-title":"Neurobiol Learn Mem"},{"key":"677_CR67","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neurobiolaging.2016.08.012","volume":"48","author":"M Coradazzi","year":"2016","unstructured":"Coradazzi M et al (2016) Selective noradrenaline depletion impairs working memory and hippocampal neurogenesis. Neurobiol Aging 48:93\u2013102","journal-title":"Neurobiol Aging"},{"key":"677_CR68","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacc.2019.10.062","volume":"75","author":"M Cortes-Canteli","year":"2020","unstructured":"Cortes-Canteli M, Iadecola C (2020) Alzheimer\u2019s disease and vascular aging. J Am Coll Cardiol 75:942\u2013951","journal-title":"J Am Coll Cardiol"},{"key":"677_CR69","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/acn3.57","volume":"1","author":"L Coutellier","year":"2014","unstructured":"Coutellier L, Ardestani PM, Shamloo M (2014) \u03b21-adrenergic receptor activation enhances memory in Alzheimer\u2019s disease model. Ann Clin Transl Neur 1:348\u2013360","journal-title":"Ann Clin Transl Neur"},{"key":"677_CR70","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/B978-0-08-017922-3.50138-6","volume-title":"Proceedings of the third international catecholamine symposium vol. frontiers in catecholamine research","author":"T Crow","year":"1973","unstructured":"Crow T (1973) The coeruleo-cortical norepinephrine system and learning. In: Proceedings of the third international catecholamine symposium vol. frontiers in catecholamine research, pp 723\u2013726"},{"key":"677_CR71","doi-asserted-by":"publisher","unstructured":"Cunnane SC et al (2020) Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov:1\u201325. https:\/\/doi.org\/10.1038\/s41573-020-0072-x","DOI":"10.1038\/s41573-020-0072-x"},{"key":"677_CR72","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/cne.902920413","volume":"292","author":"ET Cunningham","year":"1990","unstructured":"Cunningham ET, Bohn MC, Sawchenko PE (1990) Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Comp Neurol 292:651\u2013667","journal-title":"J Comp Neurol"},{"key":"677_CR73","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/jcbfm.1981.47","volume":"1","author":"N Dahlgren","year":"1981","unstructured":"Dahlgren N, Ingvar M, Siesj\u00f6 BK (1981) Effect of propranolol on local cerebral blood flow under normocapnic and hypercapnic conditions. J Cereb Blood Flow Metabolism 1:429\u2013436","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR74","doi-asserted-by":"publisher","unstructured":"David MCB et al (2022) Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer\u2019s disease: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry:jnnp-2022-329136. https:\/\/doi.org\/10.1136\/jnnp-2022-329136","DOI":"10.1136\/jnnp-2022-329136"},{"key":"677_CR75","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1111\/j.1476-5381.2011.01647.x","volume":"165","author":"N Dehvari","year":"2012","unstructured":"Dehvari N et al (2012) \u03b22-adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C-terminal tail. Brit J Pharmacol 165:1442\u20131456","journal-title":"Brit J Pharmacol"},{"key":"677_CR76","first-page":"5","volume":"61 Suppl 1","author":"PL Delgado","year":"2000","unstructured":"Delgado PL, Moreno FA (2000) Role of norepinephrine in depression. J Clin Psychiatry 61 Suppl 1:5\u201312","journal-title":"J Clin Psychiatry"},{"key":"677_CR78","doi-asserted-by":"publisher","unstructured":"Dienel GA (2017) Noradrenergic signaling and astroglia:145\u2013166. https:\/\/doi.org\/10.1016\/b978-0-12-805088-0.00007-4","DOI":"10.1016\/b978-0-12-805088-0.00007-4"},{"key":"677_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/jnc.13630","volume":"138","author":"GA Dienel","year":"2016","unstructured":"Dienel GA, Cruz NF (2016) Aerobic glycolysis during brain activation: adrenergic regulation and influence of norepinephrine on astrocytic metabolism. J Neurochem 138:14\u201352","journal-title":"J Neurochem"},{"key":"677_CR80","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.nicl.2019.102146","volume":"25","author":"S Dolui","year":"2020","unstructured":"Dolui S, Li Z, Nasrallah IM, Detre JA, Wolk DA (2020) Arterial spin labeling versus 18F-FDG-PET to identify mild cognitive impairment. Neuroimage Clin 25:102146","journal-title":"Neuroimage Clin"},{"key":"677_CR81","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12031-012-9742-4","volume":"48","author":"J Dong","year":"2012","unstructured":"Dong J et al (2012) Beta2-adrenergic receptor and astrocyte glucose metabolism. J Mol Neurosci 48:456\u2013463","journal-title":"J Mol Neurosci"},{"key":"677_CR82","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/01.anes.0000299576.00302.4c","volume":"108","author":"JC Drummond","year":"2008","unstructured":"Drummond JC et al (2008) Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology 108:225\u2013232","journal-title":"Anesthesiology"},{"key":"677_CR83","first-page":"1625","volume":"46","author":"A Drzezga","year":"2005","unstructured":"Drzezga A et al (2005) Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Medicine Official Publ Soc Nucl Medicine 46:1625\u20131632","journal-title":"J Nucl Medicine Official Publ Soc Nucl Medicine"},{"key":"677_CR84","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/pds.4361","volume":"27","author":"Y Duan","year":"2018","unstructured":"Duan Y, Grady JJ, Albertsen PC, Wu ZH (2018) Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidem Dr S 27:340\u2013348","journal-title":"Pharmacoepidem Dr S"},{"key":"677_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2006.10.007","volume":"252","author":"T Dziedzic","year":"2007","unstructured":"Dziedzic T, Slowik A, Pera J, Szczudlik A (2007) Beta-blockers reduce the risk of early death in ischemic stroke. J Neurol Sci 252:53\u201356","journal-title":"J Neurol Sci"},{"key":"677_CR86","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1748-1716.1979.tb06478.x","volume":"107","author":"L Edvinsson","year":"1979","unstructured":"Edvinsson L, Lacombe P, Owman CH, Reynier-Rebuffel AM, Seylaz J (1979) Quantitative changes in regional cerebral blood flow of rats induced by alpha-and beta-adrenergic stimulants. Acta Physiol Scand 107:289\u2013296","journal-title":"Acta Physiol Scand"},{"key":"677_CR87","doi-asserted-by":"publisher","first-page":"R224","DOI":"10.1152\/ajpregu.1989.256.1.R224","volume":"256","author":"RM Elfont","year":"1989","unstructured":"Elfont RM, Sundaresan PR, Sladek CD (1989) Adrenergic receptors on cerebral microvessels: pericyte contribution. Am J Physiology-regulatory Integr Comp Physiology 256:R224\u2013R230","journal-title":"Am J Physiology-regulatory Integr Comp Physiology"},{"key":"677_CR88","doi-asserted-by":"publisher","first-page":"105089","DOI":"10.1016\/j.nbd.2020.105089","volume":"146","author":"AK Evans","year":"2020","unstructured":"Evans AK et al (2020) Beta-adrenergic receptor antagonism is proinflammatory and exacerbates neuroinflammation in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis 146:105089","journal-title":"Neurobiol Dis"},{"key":"677_CR89","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neurobiolaging.2021.06.012","volume":"106","author":"AK Evans","year":"2021","unstructured":"Evans AK et al (2021) Age-related neuroinflammation and pathology in the locus coeruleus and hippocampus: beta-adrenergic antagonists exacerbate impairment of learning and memory in aged mice. Neurobiol Aging 106:241\u2013256","journal-title":"Neurobiol Aging"},{"key":"677_CR90","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/syn.20520","volume":"62","author":"V Fagerholm","year":"2008","unstructured":"Fagerholm V et al (2008) Autoradiographic characterization of \u03b12C-adrenoceptors in the human striatum. Synapse 62:508\u2013515","journal-title":"Synapse"},{"key":"677_CR91","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.nbd.2011.04.011","volume":"43","author":"M Faizi","year":"2011","unstructured":"Faizi M et al (2011) Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of \u03b21-adrenergic receptor by xamoterol as a potential cognitive enhancer. Neurobiol Dis 43:397\u2013413","journal-title":"Neurobiol Dis"},{"key":"677_CR92","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/EJA.0000000000000662","volume":"34","author":"E Farag","year":"2017","unstructured":"Farag E et al (2017) The relative effects of dexmedetomidine and propofol on cerebral blood flow velocity and regional brain oxygenation. Eur J Anaesthesiol 34:732\u2013739","journal-title":"Eur J Anaesthesiol"},{"key":"677_CR93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0197-0186(02)00049-9","volume":"41","author":"DL Feinstein","year":"2002","unstructured":"Feinstein DL et al (2002) Noradrenergic regulation of inflammatory gene expression in brain. Neurochem Int 41:357\u2013365","journal-title":"Neurochem Int"},{"key":"677_CR94","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/jnc.13447","volume":"139","author":"DL Feinstein","year":"2016","unstructured":"Feinstein DL, Kalinin S, Braun D (2016) Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system. J Neurochem 139:154\u2013178","journal-title":"J Neurochem"},{"key":"677_CR95","doi-asserted-by":"publisher","first-page":"263310552095730","DOI":"10.1177\/2633105520957302","volume":"15","author":"M-L Floare","year":"2020","unstructured":"Floare M-L, Allen SP (2020) Why TDP-43? Why not? Mechanisms of metabolic dysfunction in amyotrophic lateral sclerosis. Neurosci Insights 15:2633105520957302","journal-title":"Neurosci Insights"},{"key":"677_CR96","doi-asserted-by":"publisher","first-page":"20150357","DOI":"10.1098\/rstb.2015.0357","volume":"371","author":"RD Freeman","year":"2016","unstructured":"Freeman RD, Li B (2016) Neural\u2013metabolic coupling in the central visual pathway. Philos Trans R Soc B Biological Sci 371:20150357","journal-title":"Philos Trans R Soc B Biological Sci"},{"key":"677_CR97","doi-asserted-by":"publisher","first-page":"e00655","DOI":"10.1002\/prp2.655","volume":"8","author":"L Froese","year":"2020","unstructured":"Froese L, Dian J, Gomez A, Unger B, Zeiler FA (2020) The cerebrovascular response to norepinephrine: a scoping systematic review of the animal and human literature. Pharmacol Res Perspectives 8:e00655","journal-title":"Pharmacol Res Perspectives"},{"key":"677_CR98","first-page":"261","volume":"13","author":"M Frost","year":"2020","unstructured":"Frost M et al (2020) Vascular \u03b11A adrenergic receptors as a potential therapeutic target for IPAD in Alzheimer\u2019s disease. Pharm 13:261","journal-title":"Pharm"},{"key":"677_CR99","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1007\/s11064-015-1574-5","volume":"40","author":"K Fuxe","year":"2015","unstructured":"Fuxe K, Agnati LF, Marcoli M, Borroto-Escuela DO (2015) Volume transmission in central dopamine and noradrenaline neurons and its astroglial targets. Neurochem Res 40:2600\u20132614","journal-title":"Neurochem Res"},{"key":"677_CR100","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11910-020-01087-7","volume":"21","author":"A Galgani","year":"2021","unstructured":"Galgani A et al (2021) Locus coeruleus magnetic resonance imaging in neurological diseases. Curr Neurol Neurosci 21:2","journal-title":"Curr Neurol Neurosci"},{"key":"677_CR101","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnins.2015.00220","volume":"9","author":"M Gannon","year":"2015","unstructured":"Gannon M et al (2015) Noradrenergic dysfunction in Alzheimer\u2019s disease. Front Neurosci 9:220","journal-title":"Front Neurosci"},{"key":"677_CR102","doi-asserted-by":"publisher","first-page":"8526","DOI":"10.1073\/pnas.1605063113","volume":"113","author":"V Gao","year":"2016","unstructured":"Gao V et al (2016) Astrocytic \u03b22-adrenergic receptors mediate hippocampal long-term memory consolidation. Proc Natl Acad Sci 113:8526\u20138531","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR103","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/brain\/awt152","volume":"136","author":"D Garc\u00eda-Lorenzo","year":"2013","unstructured":"Garc\u00eda-Lorenzo D et al (2013) The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson\u2019s disease. Brain 136:2120\u20132129","journal-title":"Brain"},{"key":"677_CR104","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ana.410300308","volume":"30","author":"P Gaspar","year":"1991","unstructured":"Gaspar P, Duyckaerts C, Alvarez C, Javoy-Agid F, Berger B (1991) Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson\u2019s disease. Ann Neurol 30:365\u2013374","journal-title":"Ann Neurol"},{"key":"677_CR105","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.410320510","volume":"32","author":"DC German","year":"1992","unstructured":"German DC et al (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667\u2013676","journal-title":"Ann Neurol"},{"key":"677_CR106","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11011-014-9563-y","volume":"30","author":"M Gibbs","year":"2015","unstructured":"Gibbs M (2015) Reflections on glycogen and \u03b2-amyloid: why does glycogenolytic \u03b22-adrenoceptor stimulation not rescue memory after \u03b2-amyloid? Metab Brain Dis 30:345\u2013352","journal-title":"Metab Brain Dis"},{"key":"677_CR107","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fnint.2015.00070","volume":"9","author":"ME Gibbs","year":"2016","unstructured":"Gibbs ME (2016) Role of glycogenolysis in memory and learning: regulation by noradrenaline, serotonin and ATP. Frontiers Integr Neurosci 9:70","journal-title":"Frontiers Integr Neurosci"},{"key":"677_CR108","first-page":"1301629","volume":"33","author":"ME Gibbs","year":"2007","unstructured":"Gibbs ME, Hutchinson DS, Summers RJ (2007) Role of \u03b2-adrenoceptors in memory consolidation: \u03b23-adrenoceptors act on glucose uptake and \u03b22-adrenoceptors on glycogenolysis. Neuropsychopharmacology 33:1301629","journal-title":"Neuropsychopharmacology"},{"key":"677_CR109","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijdevneu.2008.10.005","volume":"27","author":"ME Gibbs","year":"2009","unstructured":"Gibbs ME, Rodricks CL, Hutchinson DS, Summers RJ, Miller SL (2009a) Importance of adrenergic receptors in prenatally induced cognitive impairment in the domestic chick. Int J Dev Neurosci 27:27\u201335","journal-title":"Int J Dev Neurosci"},{"key":"677_CR110","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1471-4159.2009.05800.x","volume":"109","author":"ME Gibbs","year":"2009","unstructured":"Gibbs ME, Gibbs Z, Hertz L (2009b) Rescue of A\u03b21\u201342-induced memory impairment in day-old chick by facilitation of astrocytic oxidative metabolism: implications for Alzheimer\u2019s disease. J Neurochem 109:230\u2013236","journal-title":"J Neurochem"},{"key":"677_CR111","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.neurobiolaging.2008.05.018","volume":"31","author":"ME Gibbs","year":"2010","unstructured":"Gibbs ME et al (2010) Memory loss caused by \u03b2-amyloid protein is rescued by a \u03b23-adrenoceptor agonist. Neurobiol Aging 31:614\u2013624","journal-title":"Neurobiol Aging"},{"key":"677_CR112","doi-asserted-by":"publisher","unstructured":"Giorgi FS et al (2020) Locus coeruleus and neurovascular unit: from its role in physiology to its potential role in Alzheimer\u2019s disease pathogenesis. J Neurosci Res. https:\/\/doi.org\/10.1002\/jnr.24718","DOI":"10.1002\/jnr.24718"},{"key":"677_CR113","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1152\/japplphysiol.00966.2005","volume":"100","author":"H Girouard","year":"2006","unstructured":"Girouard H, Iadecola C (2006) Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 100:328\u2013335","journal-title":"J Appl Physiol"},{"key":"677_CR114","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.bbi.2010.06.015","volume":"24","author":"LC Gleeson","year":"2010","unstructured":"Gleeson LC, Ryan KJ, Griffin \u00c9W, Connor TJ, Harkin A (2010) The \u03b22-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain Behav Immun 24:1354\u20131361","journal-title":"Brain Behav Immun"},{"key":"677_CR115","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00213-019-05448-0","volume":"238","author":"BR Godlewska","year":"2021","unstructured":"Godlewska BR, Harmer CJ (2021) Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment. Psychopharmacology 238:1265\u20131278","journal-title":"Psychopharmacology"},{"key":"677_CR116","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/glia.20543","volume":"55","author":"GRJ Gordon","year":"2007","unstructured":"Gordon GRJ, Mulligan SJ, MacVicar BA (2007) Astrocyte control of the cerebrovasculature. Glia 55:1214\u20131221","journal-title":"Glia"},{"key":"677_CR117","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nature07525","volume":"456","author":"GRJ Gordon","year":"2008","unstructured":"Gordon GRJ, Choi HB, Rungta RL, Ellis-Davies GCR, MacVicar BA (2008) Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 456:745\u2013749","journal-title":"Nature"},{"key":"677_CR118","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA et al (2018) Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol 17:241\u2013250","journal-title":"Lancet Neurol"},{"key":"677_CR119","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0014-2999(96)00381-0","volume":"310","author":"B Grijalba","year":"1996","unstructured":"Grijalba B, Callado LF, Meana JJ, Garc\u00eda-Sevilla JA, Pazos A (1996) \u03b12-adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections. Eur J Pharmacol 310:83\u201393","journal-title":"Eur J Pharmacol"},{"key":"677_CR120","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/mds.108","volume":"33","author":"N Gronich","year":"2018","unstructured":"Gronich N et al (2018) \u03b22-adrenoceptor agonists and antagonists and risk of Parkinson\u2019s disease. Movement Disord 33:1465\u20131471","journal-title":"Movement Disord"},{"key":"677_CR121","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neurobiolaging.2006.02.007","volume":"28","author":"A Grudzien","year":"2007","unstructured":"Grudzien A et al (2007) Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer\u2019s disease. Neurobiol Aging 28:327\u2013335","journal-title":"Neurobiol Aging"},{"key":"677_CR122","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature13165","volume":"508","author":"CN Hall","year":"2014","unstructured":"Hall CN et al (2014) Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508:55\u201360","journal-title":"Nature"},{"key":"677_CR123","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1148\/radiol.2016150789","volume":"281","author":"S Haller","year":"2016","unstructured":"Haller S et al (2016) Arterial spin labeling perfusion of the brain: emerging clinical applications. Radiology 281:337\u2013356","journal-title":"Radiology"},{"key":"677_CR124","doi-asserted-by":"publisher","first-page":"201712268","DOI":"10.1073\/pnas.1712268115","volume":"115","author":"D H\u00e4mmerer","year":"2018","unstructured":"H\u00e4mmerer D et al (2018) Locus coeruleus integrity in old age is selectively related to memories linked with salient negative events. Proc Natl Acad Sci 115:201712268","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR125","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.biopsych.2012.06.013","volume":"73","author":"T Hammerschmidt","year":"2013","unstructured":"Hammerschmidt T et al (2013) Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP\/PS1 mice. Biol Psychiatry 73:454\u2013463","journal-title":"Biol Psychiatry"},{"key":"677_CR126","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1523\/JNEUROSCI.02-04-00409.1982","volume":"2","author":"S Harik","year":"1982","unstructured":"Harik S, Busto R, Martinez E (1982) Norepinephrine regulation of cerebral glycogen utilization during seizures and ischemia. J Neurosci 2:409\u2013414","journal-title":"J Neurosci"},{"key":"677_CR127","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0278-5846(87)90015-7","volume":"11","author":"CW Harley","year":"1987","unstructured":"Harley CW (1987) A role for norepinephrine in arousal, emotion and learning?: limbic modulation by norepinephrine and the Kety hypothesis. Prog Neuro-psychopharmacol Biol Psychiatry 11:419\u2013458","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"677_CR128","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/sj.npp.1300004","volume":"28","author":"CJ Harmer","year":"2003","unstructured":"Harmer CJ et al (2003) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28:148\u2013152","journal-title":"Neuropsychopharmacology"},{"key":"677_CR129","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1176\/appi.ajp.2009.09020149","volume":"166","author":"CJ Harmer","year":"2009","unstructured":"Harmer CJ et al (2009) Effect of acute antidepressant administration on negative affective bias in depressed patients. Am J Psychiat 166:1178\u20131184","journal-title":"Am J Psychiat"},{"key":"677_CR130","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Movement Disord 23:837\u2013844","journal-title":"Movement Disord"},{"key":"677_CR131","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","volume":"26","author":"MT Heneka","year":"2006","unstructured":"Heneka MT et al (2006) Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 26:1343\u20131354","journal-title":"J Neurosci"},{"key":"677_CR132","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00702-010-0438-z","volume":"117","author":"MT Heneka","year":"2010","unstructured":"Heneka MT, O\u2019Banion MK, Terwel D, Kummer MP (2010a) Neuroinflammatory processes in Alzheimer\u2019s disease. J Neural Transm 117:919\u2013947","journal-title":"J Neural Transm"},{"key":"677_CR133","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1073\/pnas.0909586107","volume":"107","author":"MT Heneka","year":"2010","unstructured":"Heneka MT et al (2010b) Locus ceruleus controls Alzheimer\u2019s disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci 107:6058\u20136063","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR134","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/jcbfm.2014.40","volume":"34","author":"CJL Heron","year":"2014","unstructured":"Heron CJL et al (2014) Comparing cerebral perfusion in Alzheimer\u2019s disease and Parkinson\u2019s disease dementia: an ASL-MRI study. J Cereb Blood Flow Metabolism 34:964\u2013970","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR135","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/0269881104042625","volume":"18","author":"N Herrmann","year":"2004","unstructured":"Herrmann N, Lanct\u00f4t KL, Eryavec G, Khan LR (2004) Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer\u2019s disease patients. J Psychopharmacol 18:215\u2013220","journal-title":"J Psychopharmacol"},{"key":"677_CR136","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.neuint.2010.03.019","volume":"57","author":"L Hertz","year":"2010","unstructured":"Hertz L, Lovatt D, Goldman SA, Nedergaard M (2010) Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca2+]i. Neurochem Int 57:411\u2013420","journal-title":"Neurochem Int"},{"key":"677_CR137","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fnint.2013.00020","volume":"7","author":"L Hertz","year":"2013","unstructured":"Hertz L et al (2013) Brain glycogenolysis, adrenoceptors, pyruvate carboxylase, Na+, K+-ATPase and Marie E. Gibbs\u2019 pioneering learning studies. Frontiers Integr Neurosci 7:20","journal-title":"Frontiers Integr Neurosci"},{"key":"677_CR138","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11011-014-9536-1","volume":"30","author":"L Hertz","year":"2014","unstructured":"Hertz L et al (2014) Astrocytic glycogenolysis: mechanisms and functions. Metab Brain Dis 30:317\u2013333","journal-title":"Metab Brain Dis"},{"key":"677_CR139","first-page":"267","volume":"47","author":"JP Hieble","year":"1995","unstructured":"Hieble JP et al (1995) International Union of pharmacology for nomenclature of adrenoceptors: consensus update. Pharmacol Rev 47:267\u2013270","journal-title":"Pharmacol Rev"},{"key":"677_CR140","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mdc3.12455","volume":"4","author":"VK Hinson","year":"2017","unstructured":"Hinson VK, Delambo A, Elm J, Turner T (2017) A randomized clinical trial of atomoxetine for mild cognitive impairment in Parkinson\u2019s disease. Mov Disord Clin Pract 4:416\u2013423","journal-title":"Mov Disord Clin Pract"},{"key":"677_CR141","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nm0198-097","volume":"4","author":"L Holcomb","year":"1998","unstructured":"Holcomb L et al (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97\u2013100","journal-title":"Nat Med"},{"key":"677_CR142","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1212\/WNL.0000000000007694","volume":"93","author":"F Hopfner","year":"2019","unstructured":"Hopfner F et al (2019) Use of \u03b22-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease. Neurology 93:e135\u2013e142","journal-title":"Neurology"},{"key":"677_CR143","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1474-4422(19)30400-4","volume":"19","author":"F Hopfner","year":"2020","unstructured":"Hopfner F et al (2020) \u03b2-adrenoreceptors and the risk of Parkinson\u2019s disease. Lancet Neurol 19:247\u2013254","journal-title":"Lancet Neurol"},{"key":"677_CR144","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ceca.2016.01.002","volume":"59","author":"A Horvat","year":"2016","unstructured":"Horvat A, Zorec R, Vardjan N (2016) Adrenergic stimulation of single rat astrocytes results in distinct temporal changes in intracellular Ca2+ and cAMP-dependent PKA responses. Cell Calcium 59:156\u2013163","journal-title":"Cell Calcium"},{"key":"677_CR145","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/00004647-200006000-00001","volume":"20","author":"R Huang","year":"2000","unstructured":"Huang R, Chen Y, Yu ACH, Hertz L (2000) Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its neuroprotective activity. J Cereb Blood Flow Metabolism 20:895\u2013898","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR146","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00002093-199601020-00007","volume":"10","author":"F Huff","year":"1996","unstructured":"Huff F et al (1996) A treatment and withdrawal trial of besipirdine in Alzheimer disease. Alz Dis Assoc Dis 10:93\u2013102","journal-title":"Alz Dis Assoc Dis"},{"key":"677_CR147","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1471-4159.2007.04789.x","volume":"103","author":"DS Hutchinson","year":"2007","unstructured":"Hutchinson DS, Summers RJ, Gibbs ME (2007) \u03b22- and \u03b23-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement? J Neurochem 103:997\u20131008","journal-title":"J Neurochem"},{"key":"677_CR148","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1471-4159.2011.07261.x","volume":"117","author":"DS Hutchinson","year":"2011","unstructured":"Hutchinson DS, Catus SL, Merlin J, Summers RJ, Gibbs ME (2011) \u03b12-adrenoceptors activate noradrenaline-mediated glycogen turnover in chick astrocytes. J Neurochem 117:915\u2013926","journal-title":"J Neurochem"},{"key":"677_CR149","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola C (2017) The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 96:17\u201342","journal-title":"Neuron"},{"key":"677_CR150","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/ncomms11934","volume":"7","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina Y et al (2016) Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun 7:11934","journal-title":"Nat Commun"},{"key":"677_CR151","doi-asserted-by":"publisher","unstructured":"Jacobs HIL, Riphagen JM, Ramakers IHGB, Verhey FRJ (2019) Alzheimer\u2019s disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms. Mol Psychiatry:1\u201310. https:\/\/doi.org\/10.1038\/s41380-019-0437-x","DOI":"10.1038\/s41380-019-0437-x"},{"key":"677_CR152","doi-asserted-by":"publisher","first-page":"eabj2511","DOI":"10.1126\/scitranslmed.abj2511","volume":"13","author":"HIL Jacobs","year":"2021","unstructured":"Jacobs HIL et al (2021) In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer\u2019s disease pathology and cognitive decline. Sci Transl Med 13:eabj2511","journal-title":"Sci Transl Med"},{"key":"677_CR153","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuint.2010.02.001","volume":"57","author":"D Jardanhazi-Kurutz","year":"2010","unstructured":"Jardanhazi-Kurutz D et al (2010) Induced LC degeneration in APP\/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits. Neurochem Int 57:375\u2013382","journal-title":"Neurochem Int"},{"key":"677_CR154","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1093\/brain\/aww128","volume":"139","author":"PO Jenkins","year":"2016","unstructured":"Jenkins PO, Mehta MA, Sharp DJ (2016) Catecholamines and cognition after traumatic brain injury. Brain 139:2345\u20132371","journal-title":"Brain"},{"key":"677_CR155","doi-asserted-by":"publisher","first-page":"277S","DOI":"10.1111\/j.1365-2125.1983.tb05876.x","volume":"15","author":"P Jenner","year":"1983","unstructured":"Jenner P, Sheehy M, Marsden C (1983) Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson\u2019s disease. Brit J Clin Pharmaco 15:277S\u2013289S","journal-title":"Brit J Clin Pharmaco"},{"key":"677_CR156","doi-asserted-by":"publisher","first-page":"105816","DOI":"10.1016\/j.nbd.2022.105816","volume":"172","author":"S-X Jin","year":"2022","unstructured":"Jin S-X, Liu L, Li S, Meunier AL, Selkoe DJ (2022) A\u03b2 oligomers from human brain impair mossy fiber LTP in CA3 of hippocampus, but activating cAMP-PKA and cGMP-PKG prevents this. Neurobiol Dis 172:105816","journal-title":"Neurobiol Dis"},{"key":"677_CR157","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/syn.890100306","volume":"10","author":"JN Joyce","year":"1992","unstructured":"Joyce JN et al (1992) Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics. Synapse 10:228\u2013246","journal-title":"Synapse"},{"key":"677_CR158","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0014-2999(02)01814-9","volume":"446","author":"V Junker","year":"2002","unstructured":"Junker V et al (2002) Stimulation of \u03b2-adrenoceptors activates astrocytes and provides neuroprotection. Eur J Pharmacol 446:25\u201336","journal-title":"Eur J Pharmacol"},{"key":"677_CR159","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-020-0886-0","volume":"8","author":"SS Kaalund","year":"2020","unstructured":"Kaalund SS et al (2020) Locus coeruleus pathology in progressive supranuclear palsy, and its relation to disease severity. Acta Neuropathologica Commun 8:11","journal-title":"Acta Neuropathologica Commun"},{"key":"677_CR160","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","volume":"7","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk R et al (2011) Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimers Dement 7:309\u2013317","journal-title":"Alzheimers Dement"},{"key":"677_CR161","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0304-3940(89)90231-0","volume":"106","author":"RN Kalaria","year":"1989","unstructured":"Kalaria RN, Harik SI (1989) Increased \u03b12- and \u03b22-adrenergic receptors in cerebral microvessels in Alzheimer disease. Neurosci Lett 106:233\u2013238","journal-title":"Neurosci Lett"},{"key":"677_CR162","first-page":"367","volume":"317","author":"RN Kalaria","year":"1989","unstructured":"Kalaria RN, Andorn AC, Harik SI (1989a) Alterations in adrenergic receptors of frontal cortex and cerebral microvessels in Alzheimer\u2019s disease and aging. Prog Clin Biol Res 317:367\u2013374","journal-title":"Prog Clin Biol Res"},{"key":"677_CR163","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1111\/j.1471-4159.1989.tb09242.x","volume":"53","author":"RN Kalaria","year":"1989","unstructured":"Kalaria RN et al (1989b) Adrenergic receptors in aging and Alzheimer\u2019s disease: increased \u03b22-receptors in prefrontal cortex and hippocampus. J Neurochem 53:1772\u20131781","journal-title":"J Neurochem"},{"key":"677_CR164","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.neurobiolaging.2006.06.003","volume":"28","author":"S Kalinin","year":"2007","unstructured":"Kalinin S et al (2007) Noradrenaline deficiency in brain increases \u03b2-amyloid plaque burden in an animal model of Alzheimer\u2019s disease. Neurobiol Aging 28:1206\u20131214","journal-title":"Neurobiol Aging"},{"key":"677_CR165","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.neurobiolaging.2011.04.012","volume":"33","author":"S Kalinin","year":"2012","unstructured":"Kalinin S et al (2012) The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging 33:1651\u20131663","journal-title":"Neurobiol Aging"},{"key":"677_CR166","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jmri.22515","volume":"33","author":"K Kamagata","year":"2011","unstructured":"Kamagata K et al (2011) Posterior hypoperfusion in Parkinson\u2019s disease with and without dementia measured with arterial spin labeling MRI. J Magn Reson Imaging 33:803\u2013807","journal-title":"J Magn Reson Imaging"},{"key":"677_CR167","volume-title":"Basic & clinical pharmacology","author":"BG Katzung","year":"2017","unstructured":"Katzung BG (2017) Chapter 6: Introduction to autonomic pharmacology cholinergic transmission adrenergic transmission cotransmitters in cholinergic & adrenergic nerves central integration. In: Katzung B (ed) Basic & clinical pharmacology"},{"key":"677_CR168","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40478-017-0411-2","volume":"5","author":"SC Kelly","year":"2017","unstructured":"Kelly SC et al (2017) Locus coeruleus cellular and molecular pathology during the progression of Alzheimer\u2019s disease. Acta Neuropathologica Commun 5:8","journal-title":"Acta Neuropathologica Commun"},{"key":"677_CR169","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3233\/JAD-190090","volume":"70","author":"SC Kelly","year":"2019","unstructured":"Kelly SC et al (2019) Locus coeruleus degeneration induces forebrain vascular pathology in a transgenic rat model of Alzheimer\u2019s disease. J Alzheimers Dis 70:371\u2013388","journal-title":"J Alzheimers Dis"},{"key":"677_CR170","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroimage.2015.03.020","volume":"113","author":"NI Keren","year":"2015","unstructured":"Keren NI et al (2015) Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. NeuroImage 113:235\u2013245","journal-title":"NeuroImage"},{"key":"677_CR171","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0895-6111(89)90077-3","volume":"13","author":"GN Ko","year":"1989","unstructured":"Ko GN et al (1989) Localization and measurement of neurotransmitter receptors in rat and human brain by quantitative autoradiography. Comput Med Imag Grap 13:37\u201345","journal-title":"Comput Med Imag Grap"},{"key":"677_CR172","unstructured":"Kochanek KD, Murphy S, Xu J, Arias E (2017) Mortality in the United States, 2016. NCHS Data Brief:1\u20138"},{"key":"677_CR173","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40261-019-00771-y","volume":"39","author":"G Koren","year":"2019","unstructured":"Koren G, Norton G, Radinsky K, Shalev V (2019) Chronic use of \u03b2-blockers and the risk of Parkinson\u2019s disease. Clin Drug Invest 39:463\u2013468","journal-title":"Clin Drug Invest"},{"key":"677_CR174","first-page":"199","volume":"26","author":"RM Kostrzewa","year":"1974","unstructured":"Kostrzewa RM, Jacobowitz DM (1974) Pharmacological actions of 6-hydroxydopamine. Pharmacol Rev 26:199\u2013288","journal-title":"Pharmacol Rev"},{"key":"677_CR332","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(77)91660-9","volume":"309","author":"Lancet","year":"1977","unstructured":"Lancet (1977) Cardiogenic dementia. Lancet 309:27\u201328","journal-title":"Lancet"},{"key":"677_CR175","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1002\/cne.23363","volume":"521","author":"A Lampron","year":"2013","unstructured":"Lampron A, Pimentel-Coelho PM, Rivest S (2013) Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration. J Comp Neurol 521:3863\u20133876","journal-title":"J Comp Neurol"},{"key":"677_CR176","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fnmol.2018.00254","volume":"11","author":"G Leanza","year":"2018","unstructured":"Leanza G, Gulino R, Zorec R (2018) Noradrenergic hypothesis linking neurodegeneration-based cognitive decline and astroglia. Front Mol Neurosci 11:254","journal-title":"Front Mol Neurosci"},{"key":"677_CR177","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12974-019-1506-4","volume":"16","author":"KJ Lechtenberg","year":"2019","unstructured":"Lechtenberg KJ, Meyer ST, Doyle JB, Peterson TC, Buckwalter MS (2019) Augmented \u03b22-adrenergic signaling dampens the neuroinflammatory response following ischemic stroke and increases stroke size. J Neuroinflamm 16:112","journal-title":"J Neuroinflamm"},{"key":"677_CR178","doi-asserted-by":"publisher","unstructured":"Levey AI et al (2021) A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain. https:\/\/doi.org\/10.1093\/brain\/awab452","DOI":"10.1093\/brain\/awab452"},{"key":"677_CR179","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fneur.2017.00246","volume":"8","author":"W-C Lin","year":"2017","unstructured":"Lin W-C et al (2017) Autonomic function impairment and brain perfusion deficit in Parkinson\u2019s disease. Front Neurol 8:246","journal-title":"Front Neurol"},{"key":"677_CR180","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/cells9061373","volume":"9","author":"S-Y Lin","year":"2020","unstructured":"Lin S-Y et al (2020) Effects of \u03b2-adrenergic blockade on metabolic and inflammatory responses in a rat model of ischemic stroke. Cell 9:1373","journal-title":"Cell"},{"key":"677_CR181","volume-title":"Conference reports: clinical trials in Alzheimer\u2019s disease","author":"T Lodeweyckx","year":"2021","unstructured":"Lodeweyckx T et al (2021) Safety, tolerability and cerebral blood flow after single doses of the \u03b22-AR agonist, clenbuterol, in patients with mild cognitive impairment or Parkinson\u2019s disease. In: Conference reports: clinical trials in Alzheimer\u2019s disease"},{"key":"677_CR182","volume-title":"Conference report #338: AD\/PD Alzheimer\u2019s and Parkinson\u2019s diseases conference","author":"T Lodeweyckx","year":"2023","unstructured":"Lodeweyckx T et al (2023) A phase 1 safety, pharmacokinetics and pharmacodynamics study of CST-2032: a novel, selective, CNS-penetrating beta-2 adrenoceptor agonist for treatment of cognitive impairment. In: Conference report #338: AD\/PD Alzheimer\u2019s and Parkinson\u2019s diseases conference"},{"key":"677_CR183","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fphys.2018.00913","volume":"9","author":"CF Louren\u00e7o","year":"2018","unstructured":"Louren\u00e7o CF, Ledo A, Caetano M, Barbosa RM, Laranjinha J (2018) Age-dependent impairment of neurovascular and neurometabolic coupling in the hippocampus. Front Physiol 9:913","journal-title":"Front Physiol"},{"key":"677_CR184","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0166-4328(89)80121-4","volume":"33","author":"J Luthman","year":"1989","unstructured":"Luthman J, Fredriksson A, Sundstr\u00f6m E, Jonsson G, Archer T (1989) Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage. Behav Brain Res 33:267\u2013277","journal-title":"Behav Brain Res"},{"key":"677_CR185","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/ajplegacy.1976.231.2.489","volume":"231","author":"E MacKenzie","year":"1976","unstructured":"MacKenzie E, McCulloch J, Harper A (1976) Influence of endogenous norepinephrine on cerebral blood flow and metabolism. Am J Physiology-legacy Content 231:489\u2013494","journal-title":"Am J Physiology-legacy Content"},{"key":"677_CR186","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/jcbfm.1995.60","volume":"15","author":"PL Madsen","year":"1994","unstructured":"Madsen PL et al (1994) Persistent resetting of the cerebral oxygen\/glucose uptake ratio by brain activation: evidence obtained with the Kety \u2013 Schmidt technique. J Cereb Blood Flow Metabolism 15:485\u2013491","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR187","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3233\/JAD-191151","volume":"74","author":"M Malek-Ahmadi","year":"2020","unstructured":"Malek-Ahmadi M, Perez SE, Chen K, Mufson EJ (2020) Braak stage, cerebral amyloid angiopathy, and cognitive decline in early Alzheimer\u2019s disease. J Alzheimers Dis 74:189\u2013197","journal-title":"J Alzheimers Dis"},{"key":"677_CR188","doi-asserted-by":"publisher","first-page":"738465","DOI":"10.3389\/fneur.2021.738465","volume":"12","author":"M Malek-Ahmadi","year":"2021","unstructured":"Malek-Ahmadi M, Su Y, Jansen WJ (2021) Editorial: vascular factors and vascular lesions in pre-clinical Alzheimer\u2019s disease. Front Neurol 12:738465","journal-title":"Front Neurol"},{"key":"677_CR189","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/jnnp.45.2.113","volume":"45","author":"DM Mann","year":"1982","unstructured":"Mann DM, Yates PO, Hawkes J (1982) The noradrenergic system in Alzheimer and multi-infarct dementias. J Neurol Neurosurg Psychiatry 45:113","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"677_CR190","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1523\/JNEUROSCI.15-01-00152.1995","volume":"15","author":"P Mantyh","year":"1995","unstructured":"Mantyh P et al (1995) Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J Neurosci 15:152\u2013164","journal-title":"J Neurosci"},{"key":"677_CR191","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.brainresrev.2004.02.002","volume":"45","author":"MR Marien","year":"2004","unstructured":"Marien MR, Colpaert FC, Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 45:38\u201378","journal-title":"Brain Res Rev"},{"key":"677_CR192","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/mds.22307","volume":"24","author":"L Marsh","year":"2009","unstructured":"Marsh L, Biglan K, Gerstenhaber M, Williams JR (2009) Atomoxetine for the treatment of executive dysfunction in Parkinson\u2019s disease: a pilot open-label study. Movement Disord 24:277\u2013282","journal-title":"Movement Disord"},{"key":"677_CR193","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-020-02248-1","volume":"141","author":"BJ Matchett","year":"2021","unstructured":"Matchett BJ, Grinberg LT, Theofilas P, Murray ME (2021) The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol 141:631\u2013650","journal-title":"Acta Neuropathol"},{"key":"677_CR194","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.tics.2016.01.001","volume":"20","author":"M Mather","year":"2016","unstructured":"Mather M, Harley CW (2016) The locus coeruleus: essential for maintaining cognitive function and the aging brain. Trends Cogn Sci 20:214\u2013226","journal-title":"Trends Cogn Sci"},{"key":"677_CR195","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1017\/S0140525X15000667","volume":"39","author":"M Mather","year":"2016","unstructured":"Mather M, Clewett D, Sakaki M, Harley CW (2016) Norepinephrine ignites local hotspots of neuronal excitation: how arousal amplifies selectivity in perception and memory. Behav Brain Sci 39:e200","journal-title":"Behav Brain Sci"},{"key":"677_CR196","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0002-9440(10)64085-0","volume":"158","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka Y et al (2001) Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease. Am J Pathol 158:1345\u20131354","journal-title":"Am J Pathol"},{"key":"677_CR331","doi-asserted-by":"publisher","first-page":"1214102","DOI":"10.3389\/fmolb.2023.1214102","volume":"10","author":"RA Matt","year":"2023","unstructured":"Matt RA, Westhorpe FG, Romuar RF, Rana P, Gever JR, Ford AP (2023) Fingerprinting heterocellular \u03b2-adrenoceptor functional expression in the brain using agonist activity profiles. Front Mol Biosci 10:1214102. https:\/\/doi.org\/10.3389\/fmolb.2023.1214102","journal-title":"Front Mol Biosci"},{"key":"677_CR197","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0006-3223(01)01235-5","volume":"51","author":"KL Matthews","year":"2002","unstructured":"Matthews KL et al (2002) Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry 51:407\u2013416","journal-title":"Biol Psychiatry"},{"key":"677_CR198","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.brainres.2010.12.015","volume":"1373","author":"PJ McMillan","year":"2011","unstructured":"McMillan PJ et al (2011) Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson\u2019s disease and Alzheimer\u2019s disease. Brain Res 1373:240\u2013252","journal-title":"Brain Res"},{"key":"677_CR199","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuropharm.2010.03.014","volume":"59","author":"EN McNamee","year":"2010","unstructured":"McNamee EN et al (2010) Noradrenaline acting at \u03b2-adrenoceptors induces expression of IL-1\u03b2 and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology 59:37\u201348","journal-title":"Neuropharmacology"},{"key":"677_CR200","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/syn.21789","volume":"69","author":"MR Mirbolooki","year":"2015","unstructured":"Mirbolooki MR, Schade KN, Constantinescu CC, Pan M, Mukherjee J (2015) Enhancement of 18F-fluorodeoxyglucose metabolism in rat brain frontal cortex using a \u03b23 adrenoceptor agonist. Synapse 69:96\u201398","journal-title":"Synapse"},{"key":"677_CR201","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1447-0594.2007.00385.x","volume":"7","author":"M Mishina","year":"2007","unstructured":"Mishina M et al (2007) Correlation between each task of the mini-mental state examination and regional glucose hypometabolism in at-rest Alzheimer\u2019s disease patients. Geriatr Gerontol Int 7:124\u2013130","journal-title":"Geriatr Gerontol Int"},{"key":"677_CR202","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.aaf3934","volume":"357","author":"S Mittal","year":"2017","unstructured":"Mittal S et al (2017) \u03b22-adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson\u2019s disease. Science 357:891\u2013898","journal-title":"Science"},{"key":"677_CR203","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/JGP.0b013e3181aad585","volume":"17","author":"RC Mohs","year":"2009","unstructured":"Mohs RC et al (2009) Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study. Am J Geriatric Psychiatry 17:752\u2013759","journal-title":"Am J Geriatric Psychiatry"},{"key":"677_CR204","doi-asserted-by":"publisher","first-page":"11010","DOI":"10.1073\/pnas.1817347116","volume":"116","author":"H Monai","year":"2019","unstructured":"Monai H et al (2019) Adrenergic receptor antagonism induces neuroprotection and facilitates recovery from acute ischemic stroke. Proc Natl Acad Sci 116:11010\u201311019","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR205","doi-asserted-by":"publisher","first-page":"8150","DOI":"10.1038\/s41598-021-87609-w","volume":"11","author":"H Monai","year":"2021","unstructured":"Monai H et al (2021) Adrenergic inhibition facilitates normalization of extracellular potassium after cortical spreading depolarization. Sci Rep-UK 11:8150","journal-title":"Sci Rep-UK"},{"key":"677_CR206","doi-asserted-by":"publisher","first-page":"JPET-AR-2020-00","DOI":"10.1124\/jpet.120.000176","volume":"376","author":"CL Moore","year":"2021","unstructured":"Moore CL et al (2021) Metoprolol impairs beta1 adrenergic receptor-mediated vasodilation in rat cerebral arteries: implications for beta-blocker therapy. J Pharmacol Exp Ther 376:JPET-AR-2020-000176","journal-title":"J Pharmacol Exp Ther"},{"key":"677_CR207","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0024-3205(96)00632-7","volume":"60","author":"D Morin","year":"1996","unstructured":"Morin D, Sapena R, Zini R, Onteniente B, Tillement J-P (1996) Characterization of \u03b2-adrenergic receptors of freshly isolated astrocytes and neurons from rat brain. Life Sci 60:315\u2013324","journal-title":"Life Sci"},{"key":"677_CR208","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, Leon MJD (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci 1147:180\u2013195","journal-title":"Ann N Y Acad Sci"},{"key":"677_CR209","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.nic.2005.09.008","volume":"15","author":"SG Mueller","year":"2005","unstructured":"Mueller SG et al (2005) The Alzheimer\u2019s disease neuroimaging initiative. Neuroimaging Clin N Am 15:869\u2013877","journal-title":"Neuroimaging Clin N Am"},{"key":"677_CR210","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jalz.2011.06.003","volume":"8","author":"ES Musiek","year":"2012","unstructured":"Musiek ES et al (2012) Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer\u2019s disease. Alzheimers Dement 8:51\u201359","journal-title":"Alzheimers Dement"},{"key":"677_CR211","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ana.25341","volume":"84","author":"SS Nielsen","year":"2018","unstructured":"Nielsen SS, Gross A, Camacho-Soto A, Willis AW, Racette BA (2018) \u03b22-adrenoreceptor medications and risk of Parkinson disease. Ann Neurol 84:683\u2013693","journal-title":"Ann Neurol"},{"key":"677_CR212","first-page":"73","volume":"24","author":"AR Nippert","year":"2018","unstructured":"Nippert AR, Biesecker KR, Newman EA (2018) Mechanisms mediating functional hyperemia in the brain. Neurosci 24:73\u201383","journal-title":"Neurosci"},{"key":"677_CR213","doi-asserted-by":"publisher","unstructured":"O\u2019Callaghan C et al (2021) Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson\u2019s disease. Brain:awab142. https:\/\/doi.org\/10.1093\/brain\/awab142","DOI":"10.1093\/brain\/awab142"},{"key":"677_CR214","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1007\/s11064-012-0818-x","volume":"37","author":"J O\u2019Donnell","year":"2012","unstructured":"O\u2019Donnell J, Zeppenfeld D, McConnell E, Pena S, Nedergaard M (2012) Norepinephrine: a neuromodulator that boosts the function of multiple cell types to optimize CNS performance. Neurochem Res 37:2496\u20132512","journal-title":"Neurochem Res"},{"key":"677_CR215","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mvr.2006.08.004","volume":"73","author":"K Oishi","year":"2007","unstructured":"Oishi K, Kamiyashiki T, Ito Y (2007) Isometric contraction of microvascular pericytes from mouse brain parenchyma. Microvasc Res 73:20\u201328","journal-title":"Microvasc Res"},{"key":"677_CR216","doi-asserted-by":"publisher","first-page":"e02176","DOI":"10.1002\/brb3.2176","volume":"11","author":"A Ovsenik","year":"2021","unstructured":"Ovsenik A, Podbregar M, Fabjan A (2021) Cerebral blood flow impairment and cognitive decline in heart failure. Brain Behav 11:e02176","journal-title":"Brain Behav"},{"key":"677_CR217","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(87)91408-9","volume":"401","author":"AM Palmer","year":"1987","unstructured":"Palmer AM, Wilcock GK, Esiri MM, Francis PT, Bowen DM (1987) Monoaminergic innervation of the frontal and temporal lobes in Alzheimer\u2019s disease. Brain Res 401:231\u2013238","journal-title":"Brain Res"},{"key":"677_CR218","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mehy.2013.11.016","volume":"82","author":"R Pamphlett","year":"2014","unstructured":"Pamphlett R (2014) Uptake of environmental toxicants by the locus ceruleus: a potential trigger for neurodegenerative, demyelinating and psychiatric disorders. Med Hypotheses 82:97\u2013104","journal-title":"Med Hypotheses"},{"key":"677_CR219","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0006-8993(92)91196-L","volume":"585","author":"J Pascual","year":"1992","unstructured":"Pascual J, del Arco C, Gonz\u00e1lez AM, Pazos A (1992) Quantitative light microscopic autoradiographic localization of \u03b12-adrenoceptors in the human brain. Brain Res 585:116\u2013127","journal-title":"Brain Res"},{"key":"677_CR220","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/(SICI)1098-1136(199606)17:2<133::AID-GLIA5>3.0.CO;2-3","volume":"17","author":"CD Paspalas","year":"1996","unstructured":"Paspalas CD, Papadopoulos GC (1996) Ultrastructural relationships between noradrenergic nerve fibers and non-neuronal elements in the rat cerebral cortex. Glia 17:133\u2013146","journal-title":"Glia"},{"key":"677_CR221","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41531-022-00322-x","volume":"8","author":"JR Patterson","year":"2022","unstructured":"Patterson JR et al (2022) Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein. Npj Park Dis 8:61","journal-title":"Npj Park Dis"},{"key":"677_CR222","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0006-8993(85)90977-1","volume":"358","author":"A Pazos","year":"1985","unstructured":"Pazos A, Probst A, Palacios JM (1985) \u03b2-Adrenoceptor subtypes in the human brain: autoradiographic localization. Brain Res 358:324\u2013328","journal-title":"Brain Res"},{"key":"677_CR223","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci 91:10625\u201310629","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR224","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature05193","volume":"443","author":"CM Peppiatt","year":"2006","unstructured":"Peppiatt CM, Howarth C, Mobbs P, Attwell D (2006) Bidirectional control of CNS capillary diameter by pericytes. Nature 443:700\u2013704","journal-title":"Nature"},{"key":"677_CR225","doi-asserted-by":"publisher","first-page":"581098","DOI":"10.3389\/fphar.2020.581098","volume":"11","author":"DM Perez","year":"2020","unstructured":"Perez DM (2020) \u03b11-adrenergic receptors in neurotransmission, synaptic plasticity, and cognition. Front Pharmacol 11:581098","journal-title":"Front Pharmacol"},{"key":"677_CR226","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.wad.0000155067.16313.5e","volume":"19","author":"ER Peskind","year":"2005","unstructured":"Peskind ER et al (2005) Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease. Alz Dis Assoc Dis 19:23\u201328","journal-title":"Alz Dis Assoc Dis"},{"key":"677_CR227","doi-asserted-by":"publisher","first-page":"103780","DOI":"10.1155\/2014\/103780","volume":"2014","author":"L Peterson","year":"2014","unstructured":"Peterson L, Ismond KP, Chapman E, Flood P (2014) Potential benefits of therapeutic use of \u03b22-adrenergic receptor agonists in neuroprotection and Parkinsonus disease. J Immunol Res 2014:103780","journal-title":"J Immunol Res"},{"key":"677_CR228","doi-asserted-by":"publisher","unstructured":"Pilipovi\u0107 I et al (2022) \u03b2-adrenoceptor blockade moderates neuroinflammation in male and female EAE rats and abrogates sexual dimorphisms in the major neuroinflammatory pathways by being more efficient in males. Cell Mol Neurobiol:1\u201329. https:\/\/doi.org\/10.1007\/s10571-022-01246-z","DOI":"10.1007\/s10571-022-01246-z"},{"key":"677_CR229","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/glia.21161","volume":"59","author":"M Prebil","year":"2011","unstructured":"Prebil M, Vardjan N, Jensen J, Zorec R, Kreft M (2011) Dynamic monitoring of cytosolic glucose in single astrocytes. Glia 59:903\u2013913","journal-title":"Glia"},{"key":"677_CR230","first-page":"171","volume":"2","author":"DT Price","year":"1994","unstructured":"Price DT, Lefkowitz RJ, Caron MG, Berkowitz D, Schwinn DA (1994) Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: implications for human alpha-adrenergic physiology. Mol Pharmacol 2:171\u2013175","journal-title":"Mol Pharmacol"},{"key":"677_CR231","doi-asserted-by":"publisher","first-page":"502","DOI":"10.4103\/0253-7613.84950","volume":"43","author":"S Purkayastha","year":"2011","unstructured":"Purkayastha S, Raven PB (2011) The functional role of the alpha-1 adrenergic receptors in cerebral blood flow regulation. Indian J Pharmacol 43:502\u2013506","journal-title":"Indian J Pharmacol"},{"key":"677_CR232","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/01.RES.43.4.485","volume":"43","author":"MJ Purves","year":"2018","unstructured":"Purves MJ (2018) Do vasomotor nerves significantly regulate cerebral blood flow? Circ Res 43:485\u2013493","journal-title":"Circ Res"},{"key":"677_CR233","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.peptides.2010.04.020","volume":"31","author":"N Pusk\u00e1s","year":"2010","unstructured":"Pusk\u00e1s N, Papp RS, Gallatz K, Palkovits M (2010) Interactions between orexin\u2013immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice. Peptides 31:1589\u20131597","journal-title":"Peptides"},{"key":"677_CR234","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JSAM Reijnders","year":"2008","unstructured":"Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG (2008) A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Movement Disord 23:183\u2013189","journal-title":"Movement Disord"},{"key":"677_CR235","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1212\/WNL.36.8.1067","volume":"36","author":"GA Reznikoff","year":"1986","unstructured":"Reznikoff GA, Manaker S, Rhodes CH, Winokur A, Rainbow TC (1986) Localization and quantification of beta-adrenergic receptors in human brain. Neurology 36:1067\u20131067","journal-title":"Neurology"},{"key":"677_CR236","doi-asserted-by":"publisher","first-page":"e12425","DOI":"10.1111\/micc.12425","volume":"25","author":"SW Rhee","year":"2018","unstructured":"Rhee SW, Rusch NJ (2018) Molecular determinants of beta-adrenergic signaling to voltage-gated K+ channels in the cerebral circulation. Microcirculation 25:e12425","journal-title":"Microcirculation"},{"key":"677_CR237","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3233\/JAD-200339","volume":"77","author":"AC Robinson","year":"2020","unstructured":"Robinson AC et al (2020) The contribution of vascular pathology toward cognitive impairment in older individuals with intermediate Braak stage tau pathology. J Alzheimers Dis 77:1005\u20131015","journal-title":"J Alzheimers Dis"},{"key":"677_CR238","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","volume":"74","author":"KS Rommelfanger","year":"2007","unstructured":"Rommelfanger KS, Weinshenker D (2007) Norepinephrine: the redheaded stepchild of Parkinson\u2019s disease. Biochem Pharmacol 74:177\u2013190","journal-title":"Biochem Pharmacol"},{"key":"677_CR239","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.nlm.2008.06.010","volume":"90","author":"B Roozendaal","year":"2008","unstructured":"Roozendaal B, Castello NA, Vedana G, Barsegyan A, McGaugh JL (2008) Noradrenergic activation of the basolateral amygdala modulates consolidation of object recognition memory. Neurobiol Learn Mem 90:576\u2013579","journal-title":"Neurobiol Learn Mem"},{"key":"677_CR240","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1093\/brain\/awx232","volume":"140","author":"JM Rorabaugh","year":"2017","unstructured":"Rorabaugh JM et al (2017) Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer\u2019s disease. Brain J Neurology 140:3023\u20133038","journal-title":"Brain J Neurology"},{"key":"677_CR241","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.2042-7158.1976.tb04659.x","volume":"28","author":"SB Ross","year":"1976","unstructured":"Ross SB, Renyi AL (1976) On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) on the active uptake of noradrenaline. J Pharm Pharmacol 28:458\u2013459","journal-title":"J Pharm Pharmacol"},{"key":"677_CR242","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12640-014-9482-z","volume":"27","author":"SB Ross","year":"2015","unstructured":"Ross SB, Stenfors C (2015) DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action. Neurotox Res 27:15\u201330","journal-title":"Neurotox Res"},{"key":"677_CR243","first-page":"29","volume":"10","author":"SB Ross","year":"1973","unstructured":"Ross SB, Johansson JG, Lindborg B, Dahlbom R (1973) Cyclizing compounds. I. Tertiary N-(2-bromobenzyl)-N-haloalkylamine with adrenergic blocking action. Acta Pharm Suec 10:29\u201342","journal-title":"Acta Pharm Suec"},{"key":"677_CR244","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ynstr.2015.09.002","volume":"2","author":"JA Ross","year":"2015","unstructured":"Ross JA, McGonigle P, Bockstaele EJV (2015) Locus coeruleus, norepinephrine and A\u03b2 peptides in Alzheimer\u2019s disease. Neurobiology Stress 2:73\u201384","journal-title":"Neurobiology Stress"},{"key":"677_CR245","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1523\/JNEUROSCI.17-14-05573.1997","volume":"17","author":"A Russo-Neustadt","year":"1997","unstructured":"Russo-Neustadt A, Cotman CW (1997) Adrenergic receptors in Alzheimer\u2019s disease brain: selective increases in the cerebella of aggressive patients. J Neurosci 17:5573\u20135580","journal-title":"J Neurosci"},{"key":"677_CR246","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.bbi.2016.02.023","volume":"56","author":"KM Ryan","year":"2016","unstructured":"Ryan KM et al (2016) Clenbuterol activates the central IL-1 system via the \u03b22-adrenoceptor without provoking inflammatory response related behaviours in rats. Brain Behav Immun 56:114\u2013129","journal-title":"Brain Behav Immun"},{"key":"677_CR247","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2377-11-21","volume":"11","author":"M Sabbagh","year":"2011","unstructured":"Sabbagh M, Cummings J (2011) Progressive cholinergic decline in Alzheimer\u2019s disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology. BMC Neurol 11:21\u201321","journal-title":"BMC Neurol"},{"key":"677_CR248","doi-asserted-by":"publisher","first-page":"7ra17","DOI":"10.1126\/scitranslmed.3000258","volume":"1","author":"A Salehi","year":"2009","unstructured":"Salehi A et al (2009) Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med 1:7ra17","journal-title":"Sci Transl Med"},{"key":"677_CR249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8324565","volume":"2020","author":"TB Sampaio","year":"2020","unstructured":"Sampaio TB, Marques NF, Binder LB, Tasca CI, Prediger RD (2020) Role of prefrontal cortex on recognition memory deficits in rats following 6-OHDA-induced locus coeruleus lesion. Oxidative Med Cell Longev 2020:1\u201310","journal-title":"Oxidative Med Cell Longev"},{"key":"677_CR250","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2174\/157015908785777193","volume":"6","author":"ER Samuels","year":"2008","unstructured":"Samuels ER, Szabadi E (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part ii: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr Neuropharmacol 6:254\u2013285","journal-title":"Curr Neuropharmacol"},{"key":"677_CR251","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.parkreldis.2015.08.024","volume":"21","author":"G Santangelo","year":"2015","unstructured":"Santangelo G et al (2015) Mild cognitive impairment in newly diagnosed Parkinson\u2019s disease: a longitudinal prospective study. Parkinsonism Relat D 21:1219\u20131226","journal-title":"Parkinsonism Relat D"},{"key":"677_CR252","doi-asserted-by":"publisher","first-page":"nrn2573","DOI":"10.1038\/nrn2573","volume":"10","author":"SJ Sara","year":"2009","unstructured":"Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:nrn2573","journal-title":"Nat Rev Neurosci"},{"key":"677_CR253","doi-asserted-by":"crossref","unstructured":"Sasane R et al (2021) Parkinson disease among patients treated for benign prostatic hyperplasia with \u03b11 adrenergic receptor antagonists. J Clin Invest 131","DOI":"10.1172\/JCI145112"},{"key":"677_CR254","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/00004647-200008000-00005","volume":"20","author":"SI Savitz","year":"2000","unstructured":"Savitz SI et al (2000) The novel \u03b2-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metabolism 20:1197\u20131204","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR255","doi-asserted-by":"publisher","first-page":"e0196363","DOI":"10.1371\/journal.pone.0196363","volume":"13","author":"R Schiffner","year":"2018","unstructured":"Schiffner R et al (2018) Underlying mechanism of subcortical brain protection during hypoxia and reoxygenation in a sheep model \u2013 influence of \u03b11-adrenergic signalling. PLoS One 13:e0196363","journal-title":"PLoS One"},{"key":"677_CR256","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2021.11.022","volume":"94","author":"JL Schultz","year":"2021","unstructured":"Schultz JL et al (2021) A pilot to assess target engagement of terazosin in Parkinson\u2019s disease. Parkinsonism Relat D 94:79\u201383","journal-title":"Parkinsonism Relat D"},{"key":"677_CR257","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrneurol.2010.71","volume":"6","author":"M Schwartz","year":"2010","unstructured":"Schwartz M, Shechter R (2010) Systemic inflammatory cells fight off neurodegenerative disease. Nat Rev Neurol 6:405\u2013410","journal-title":"Nat Rev Neurol"},{"key":"677_CR258","doi-asserted-by":"publisher","first-page":"R1051","DOI":"10.1016\/j.cub.2015.09.039","volume":"25","author":"LA Schwarz","year":"2015","unstructured":"Schwarz LA, Luo L (2015) Organization of the locus coeruleus-norepinephrine system. Curr Biol 25:R1051\u2013R1056","journal-title":"Curr Biol"},{"key":"677_CR259","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1073\/pnas.91.1.68","volume":"91","author":"A Seelig","year":"1994","unstructured":"Seelig A, Gottschlich R, Devant RM (1994) A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc Natl Acad Sci 91:68\u201372","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR260","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0006-8993(95)01567-1","volume":"717","author":"I Semkova","year":"1996","unstructured":"Semkova I, Schilling M, Henrich-Noack P, Rami A, Krieglstein J (1996) Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 717:44\u201354","journal-title":"Brain Res"},{"key":"677_CR261","doi-asserted-by":"publisher","unstructured":"Seylaz J et al (1975) Cerebral circulation and metabolism:454\u2013458. https:\/\/doi.org\/10.1007\/978-3-642-65814-3_116","DOI":"10.1007\/978-3-642-65814-3_116"},{"key":"677_CR262","doi-asserted-by":"publisher","first-page":"E3782","DOI":"10.1073\/pnas.1604977113","volume":"113","author":"BJ Shannon","year":"2016","unstructured":"Shannon BJ et al (2016) Brain aerobic glycolysis and motor adaptation learning. Proc Natl Acad Sci 113:E3782\u2013E3791","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR263","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/j.1471-4159.1986.tb00753.x","volume":"47","author":"S Shimohama","year":"1986","unstructured":"Shimohama S, Taniguchi T, Fujiwara M, Kameyama M (1986) Biochemical characterization of \u03b1-adrenergic receptors in human brain and changes in Alzheimer-type dementia. J Neurochem 47:1294\u20131301","journal-title":"J Neurochem"},{"key":"677_CR264","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/j.1471-4159.1987.tb05649.x","volume":"48","author":"S Shimohama","year":"1987","unstructured":"Shimohama S, Taniguchi T, Fujiwara M, Kameyama M (1987) Changes in \u03b2-adrenergic receptor subtypes in Alzheimer-type dementia. J Neurochem 48:1215\u20131221","journal-title":"J Neurochem"},{"key":"677_CR265","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2020.5157","volume":"78","author":"JE Simmering","year":"2021","unstructured":"Simmering JE, Welsh MJ, Liu L, Narayanan NS, Potteg\u00e5rd A (2021) Association of glycolysis-enhancing \u03b1-1 blockers with risk of developing Parkinson disease. JAMA Neurol 78:1\u20137","journal-title":"JAMA Neurol"},{"key":"677_CR266","doi-asserted-by":"publisher","first-page":"12381","DOI":"10.1038\/s41598-018-30128-y","volume":"8","author":"O Solopchuk","year":"2018","unstructured":"Solopchuk O et al (2018) Locus coeruleus atrophy doesn\u2019t relate to fatigue in Parkinson\u2019s disease. Sci Rep-UK 8:12381","journal-title":"Sci Rep-UK"},{"key":"677_CR267","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/brain\/awx348","volume":"141","author":"M Sommerauer","year":"2017","unstructured":"Sommerauer M et al (2017) Evaluation of the noradrenergic system in Parkinson\u2019s disease: an 11C-MeNER PET and neuromelanin MRI study. Brain 141:496\u2013504","journal-title":"Brain"},{"key":"677_CR268","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3348\/kjr.2015.16.5.967","volume":"16","author":"I-U Song","year":"2015","unstructured":"Song I-U, Ha S-W, Yang Y-S, Chung Y-A (2015) Differences in regional glucose metabolism of the brain measured with F-18-FDG-PET in patients with essential tremor according to their response to beta-blockers. Korean J Radiol 16:967\u2013972","journal-title":"Korean J Radiol"},{"key":"677_CR269","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s12035-018-1235-1","volume":"56","author":"S Song","year":"2019","unstructured":"Song S et al (2019) Loss of brain norepinephrine elicits neuroinflammation-mediated oxidative injury and selective caudo-rostral neurodegeneration. Mol Neurobiol 56:2653\u20132669","journal-title":"Mol Neurobiol"},{"key":"677_CR270","doi-asserted-by":"publisher","first-page":"15054","DOI":"10.1038\/s41598-020-72202-4","volume":"10","author":"S Song","year":"2020","unstructured":"Song S, Liu J, Zhang F, Hong J-S (2020) Norepinephrine depleting toxin DSP-4 and LPS alter gut microbiota and induce neurotoxicity in \u03b1-synuclein mutant mice. Sci Rep-UK 10:15054","journal-title":"Sci Rep-UK"},{"key":"677_CR271","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0006-8993(91)91538-C","volume":"563","author":"O Sorg","year":"1991","unstructured":"Sorg O, Magistretti PJ (1991) Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Res 563:227\u2013233","journal-title":"Brain Res"},{"key":"677_CR272","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/hbm.24613","volume":"40","author":"AM Staffaroni","year":"2019","unstructured":"Staffaroni AM et al (2019) A longitudinal characterization of perfusion in the aging brain and associations with cognition and neural structure. Hum Brain Mapp 40:3522\u20133533","journal-title":"Hum Brain Mapp"},{"key":"677_CR273","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2796.2006.01687.x","volume":"260","author":"MJ Stampfer","year":"2006","unstructured":"Stampfer MJ (2006) Cardiovascular disease and Alzheimer\u2019s disease: common links. J Intern Med 260:211\u2013223","journal-title":"J Intern Med"},{"key":"677_CR274","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2011.06.050","volume":"1407","author":"TS Steininger","year":"2011","unstructured":"Steininger TS, Stutz H, Kerschbaum HH (2011) Beta-adrenergic stimulation suppresses phagocytosis via Epac activation in murine microglial cells. Brain Res 1407:1\u201312","journal-title":"Brain Res"},{"key":"677_CR275","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12975-019-00718-7","volume":"11","author":"Z Sternberg","year":"2020","unstructured":"Sternberg Z, Schaller B (2020) Central noradrenergic agonists in the treatment of ischemic stroke \u2013 an overview. Transl Stroke Res 11:165\u2013184","journal-title":"Transl Stroke Res"},{"key":"677_CR276","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C et al (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci 94:13287\u201313292","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR277","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-018-0047-3","volume":"4","author":"D Sulzer","year":"2018","unstructured":"Sulzer D et al (2018) Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson\u2019s disease. Npj Park Dis 4:11","journal-title":"Npj Park Dis"},{"key":"677_CR278","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1037\/0894-4105.18.2.212","volume":"18","author":"SA Surguladze","year":"2004","unstructured":"Surguladze SA et al (2004) Recognition accuracy and response bias to happy and sad facial expressions in patients with major depression. Neuropsychology 18:212\u2013218","journal-title":"Neuropsychology"},{"key":"677_CR279","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","volume":"144","author":"A Suzuki","year":"2011","unstructured":"Suzuki A et al (2011) Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144:810\u2013823","journal-title":"Cell"},{"key":"677_CR280","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14:133","journal-title":"Nat Rev Neurol"},{"key":"677_CR281","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/0269881113490326","volume":"27","author":"E Szabadi","year":"2013","unstructured":"Szabadi E (2013) Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol 27:659\u2013693","journal-title":"J Psychopharmacol"},{"key":"677_CR282","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1523\/JNEUROSCI.4265-05.2006","volume":"26","author":"P Szot","year":"2006","unstructured":"Szot P et al (2006) Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer\u2019s disease and dementia with Lewy bodies. J Neurosci 26:467\u2013478","journal-title":"J Neurosci"},{"key":"677_CR283","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.neuroscience.2007.01.031","volume":"146","author":"P Szot","year":"2007","unstructured":"Szot P et al (2007) Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes. Neuroscience 146:471\u2013480","journal-title":"Neuroscience"},{"key":"677_CR284","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nature19325","volume":"537","author":"T Takeuchi","year":"2016","unstructured":"Takeuchi T et al (2016) Locus coeruleus and dopaminergic consolidation of everyday memory. Nature 537:357\u2013362","journal-title":"Nature"},{"key":"677_CR285","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1038\/ncomms4284","volume":"5","author":"F Tang","year":"2014","unstructured":"Tang F et al (2014) Lactate-mediated glia-neuronal signalling in the mammalian brain. Nat Commun 5:3284","journal-title":"Nat Commun"},{"key":"677_CR286","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0006-8993(82)91009-5","volume":"235","author":"H Taquet","year":"1982","unstructured":"Taquet H et al (1982) Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains. Brain Res 235:303\u2013314","journal-title":"Brain Res"},{"key":"677_CR287","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/bja\/aet122","volume":"111","author":"M Ter Laan","year":"2013","unstructured":"Ter Laan M, van Dijk JMC, Elting JWJ, Staal MJ, Absalom AR (2013) Sympathetic regulation of cerebral blood flow in humans: a review. Brit J Anaesth 111:361\u2013367","journal-title":"Brit J Anaesth"},{"key":"677_CR288","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jalz.2016.06.2362","volume":"13","author":"P Theofilas","year":"2017","unstructured":"Theofilas P et al (2017) Locus coeruleus volume and cell population changes during Alzheimer\u2019s disease progression: a stereological study in human postmortem brains with potential implication for early-stage biomarker discovery. Alzheimers Dement 13:236\u2013246","journal-title":"Alzheimers Dement"},{"key":"677_CR289","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.neuron.2018.01.008","volume":"97","author":"A Thiele","year":"2018","unstructured":"Thiele A, Bellgrove MA (2018) Neuromodulation of attention. Neuron 97:769\u2013785","journal-title":"Neuron"},{"key":"677_CR290","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/acn3.330","volume":"3","author":"D Tosun","year":"2016","unstructured":"Tosun D et al (2016) Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD. Ann Clin Transl Neur 3:740\u2013751","journal-title":"Ann Clin Transl Neur"},{"key":"677_CR291","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13195-021-00842-3","volume":"13","author":"M Tournissac","year":"2021","unstructured":"Tournissac M et al (2021) Repurposing beta-3 adrenergic receptor agonists for Alzheimer\u2019s disease: beneficial effects in a mouse model. Alzheimers Res Ther 13:103","journal-title":"Alzheimers Res Ther"},{"key":"677_CR292","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1523\/JNEUROSCI.3346-12.2013","volume":"33","author":"X Toussay","year":"2013","unstructured":"Toussay X, Basu K, Lacoste B, Hamel E (2013) Locus coeruleus stimulation recruits a broad cortical neuronal network and increases cortical perfusion. J Neurosci 33:3390\u20133401","journal-title":"J Neurosci"},{"key":"677_CR293","doi-asserted-by":"publisher","first-page":"841239","DOI":"10.3389\/fncel.2022.841239","volume":"16","author":"H Toyoda","year":"2022","unstructured":"Toyoda H et al (2022) The nature of noradrenergic volume transmission from locus coeruleus to brainstem mesencephalic trigeminal sensory neurons. Front Cell Neurosci 16:841239","journal-title":"Front Cell Neurosci"},{"key":"677_CR294","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/glia.20462","volume":"55","author":"BD Trapp","year":"2007","unstructured":"Trapp BD et al (2007) Evidence for synaptic stripping by cortical microglia. Glia 55:360\u2013368","journal-title":"Glia"},{"key":"677_CR295","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","volume":"84","author":"KD Tredici","year":"2013","unstructured":"Tredici KD, Braak H (2013) Dysfunction of the locus coeruleus\u2013norepinephrine system and related circuitry in Parkinson\u2019s disease-related dementia. J Neurol Neurosurg Psychiatry 84:774","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"677_CR296","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1161\/01.STR.17.2.202","volume":"17","author":"T Tsukahara","year":"1986","unstructured":"Tsukahara T, Taniguchi T, Shimohama S, Fujiwara M, Handa H (1986) Characterization of beta adrenergic receptors in human cerebral arteries and alteration of the receptors after subarachnoid hemorrhage. Stroke 17:202\u2013207","journal-title":"Stroke"},{"key":"677_CR297","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","volume":"5","author":"U Ungerstedt","year":"1968","unstructured":"Ungerstedt U (1968) 6-hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107\u2013110","journal-title":"Eur J Pharmacol"},{"key":"677_CR298","doi-asserted-by":"publisher","first-page":"17757","DOI":"10.1073\/pnas.1010459107","volume":"107","author":"SN Vaishnavi","year":"2010","unstructured":"Vaishnavi SN et al (2010) Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci 107:17757\u201317762","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR299","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fnagi.2019.00019","volume":"11","author":"M van der Thiel","year":"2019","unstructured":"van der Thiel M, Rodriguez C, Ville DVD, Giannakopoulos P, Haller S (2019) Regional cerebral perfusion and cerebrovascular reactivity in elderly controls with subtle cognitive deficits. Front Aging Neurosci 11:19","journal-title":"Front Aging Neurosci"},{"key":"677_CR300","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnmol.2018.00148","volume":"11","author":"N Vardjan","year":"2018","unstructured":"Vardjan N et al (2018) Enhancement of astroglial aerobic glycolysis by extracellular lactate-mediated increase in cAMP. Front Mol Neurosci 11:148","journal-title":"Front Mol Neurosci"},{"key":"677_CR301","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00702-019-02133-6","volume":"127","author":"D Vare\u0161lija","year":"2020","unstructured":"Vare\u0161lija D, Tipton KF, Davey GP, McDonald AG (2020) 6-hydroxydopamine: a far from simple neurotoxin. J Neural Transm 127:213\u2013230","journal-title":"J Neural Transm"},{"key":"677_CR302","volume-title":"Conference report #368: AD\/PD Alzheimer\u2019s and Parkinson\u2019s diseases conference","author":"G Vargas","year":"2023","unstructured":"Vargas G et al (2023) Effects of a beta-2 adrenoceptor agonist on cognition in Parkinson\u2019s disease patients with REM sleep behavior disorder. In: Conference report #368: AD\/PD Alzheimer\u2019s and Parkinson\u2019s diseases conference"},{"key":"677_CR303","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1038\/s41598-020-62864-5","volume":"10","author":"J Velebit","year":"2020","unstructured":"Velebit J et al (2020) Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca2+ signaling and dysregulated cell metabolism. Sci Rep-UK 10:6003","journal-title":"Sci Rep-UK"},{"key":"677_CR304","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/jon.12264","volume":"26","author":"S Verclytte","year":"2016","unstructured":"Verclytte S et al (2016) Cerebral hypoperfusion and hypometabolism detected by arterial spin labeling MRI and FDG-PET in early-onset Alzheimer\u2019s disease. J Neuroimaging 26:207\u2013212","journal-title":"J Neuroimaging"},{"key":"677_CR305","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","volume":"102","author":"Y Vermeiren","year":"2017","unstructured":"Vermeiren Y, Deyn PPD (2017) Targeting the norepinephrinergic system in Parkinson\u2019s disease and related disorders: the locus coeruleus story. Neurochem Int 102:22\u201332","journal-title":"Neurochem Int"},{"key":"677_CR306","doi-asserted-by":"publisher","first-page":"17763","DOI":"10.1073\/pnas.1010461107","volume":"107","author":"AG Vlassenko","year":"2010","unstructured":"Vlassenko AG et al (2010) Spatial correlation between brain aerobic glycolysis and amyloid-\u03b2 (A\u03b2) deposition. Proc Natl Acad Sci 107:17763\u201317767","journal-title":"Proc Natl Acad Sci"},{"key":"677_CR307","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/JGP.0b013e3181ab8c61","volume":"17","author":"LY Wang","year":"2009","unstructured":"Wang LY et al (2009) Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Geriatric Psychiatry 17:744\u2013751","journal-title":"Am J Geriatric Psychiatry"},{"key":"677_CR308","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/ene.13628","volume":"25","author":"J Wang","year":"2018","unstructured":"Wang J et al (2018) Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson\u2019s disease and its phenotypes. Eur J Neurol 25:949\u2013e73","journal-title":"Eur J Neurol"},{"key":"677_CR309","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.bbi.2020.01.003","volume":"87","author":"Q Wang","year":"2020","unstructured":"Wang Q et al (2020) Locus coeruleus neurons are most sensitive to chronic neuroinflammation-induced neurodegeneration. Brain Behav Immun 87:359\u2013368","journal-title":"Brain Behav Immun"},{"key":"677_CR310","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1523\/JNEUROSCI.4317-15.2016","volume":"36","author":"S Wattananit","year":"2016","unstructured":"Wattananit S et al (2016) Monocyte-derived macrophages contribute to spontaneous long-term functional recovery after stroke in mice. J Neurosci 36:4182\u20134195","journal-title":"J Neurosci"},{"key":"677_CR311","doi-asserted-by":"publisher","first-page":"342","DOI":"10.2174\/156720508784533286","volume":"5","author":"D Weinshenker","year":"2008","unstructured":"Weinshenker D (2008) Functional consequences of locus coeruleus degeneration in Alzheimer\u2019s disease. Curr Alzheimer Res 5:342\u2013345","journal-title":"Curr Alzheimer Res"},{"key":"677_CR312","doi-asserted-by":"publisher","unstructured":"Weinshenker D (2018) Long road to ruin: noradrenergic dysfunction in neurodegenerative disease. Trends Neurosci. https:\/\/doi.org\/10.1016\/j.tins.2018.01.010","DOI":"10.1016\/j.tins.2018.01.010"},{"key":"677_CR313","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1212\/WNL.0b013e3181ebdd79","volume":"75","author":"D Weintraub","year":"2010","unstructured":"Weintraub D et al (2010) Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease (LOE classification). Neurology 75:448\u2013455","journal-title":"Neurology"},{"key":"677_CR314","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.neuropharm.2014.07.001","volume":"86","author":"MA Williams","year":"2014","unstructured":"Williams MA, Li C, Kash TL, Matthews RT, Winder DG (2014) Excitatory drive onto dopaminergic neurons in the rostral linear nucleus is enhanced by norepinephrine in an \u03b11 adrenergic receptor-dependent manner. Neuropharmacology 86:116\u2013124","journal-title":"Neuropharmacology"},{"key":"677_CR315","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1212\/WNL.0b013e3182897103","volume":"80","author":"RS Wilson","year":"2013","unstructured":"Wilson RS et al (2013) Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology 80:1202\u20131208","journal-title":"Neurology"},{"key":"677_CR316","doi-asserted-by":"crossref","unstructured":"Wirth KJ (2018) Role of noradrenergic brain nuclei in the regulation of carotid artery blood flow: pharmacological evidence from anesthetized pigs with alpha-2 adrenergic receptor modulator drugs. J Alzheimers Dis:1\u201313","DOI":"10.3233\/JAD-180340"},{"key":"677_CR317","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0197-0186(94)90147-3","volume":"25","author":"C Wolfman","year":"1994","unstructured":"Wolfman C et al (1994) Recovery of central noradrenergic neurons one year after the administration of the neurotoxin DSP4. Neurochem Int 25:395\u2013400","journal-title":"Neurochem Int"},{"key":"677_CR318","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0006-8993(96)00855-4","volume":"740","author":"CC Wrenn","year":"1996","unstructured":"Wrenn CC, Picklo MJ, Lappi DA, Robertson D, Wiley RG (1996) Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings. Brain Res 740:175\u2013184","journal-title":"Brain Res"},{"key":"677_CR319","first-page":"a006346","volume":"2","author":"T Wyss-Coray","year":"2012","unstructured":"Wyss-Coray T, Rogers J (2012) Inflammation in Alzheimer disease \u2013 a brief review of the basic science and clinical literature. Csh Perspect Med 2:a006346","journal-title":"Csh Perspect Med"},{"key":"677_CR320","doi-asserted-by":"publisher","first-page":"e0180319","DOI":"10.1371\/journal.pone.0180319","volume":"12","author":"B Yi","year":"2017","unstructured":"Yi B et al (2017) Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders. PLoS One 12:e0180319","journal-title":"PLoS One"},{"key":"677_CR321","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351","journal-title":"Neuron"},{"key":"677_CR322","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainresbull.2010.11.004","volume":"84","author":"J-T Yu","year":"2011","unstructured":"Yu J-T et al (2011) Roles of \u03b2-adrenergic receptors in Alzheimer\u2019s disease: implications for novel therapeutics. Brain Res Bull 84:111\u2013117","journal-title":"Brain Res Bull"},{"key":"677_CR323","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1523\/JNEUROSCI.5025-12.2014","volume":"34","author":"J Zhang","year":"2014","unstructured":"Zhang J et al (2014) Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons. J Neurosci 34:4418\u20134431","journal-title":"J Neurosci"},{"key":"677_CR324","first-page":"35","volume":"12","author":"R Zhang","year":"2020","unstructured":"Zhang R et al (2020) Spatial distribution of (R)-salbutamol in rat brain following nasal and intravenous administration using DESI-MS. Pharm 12:35","journal-title":"Pharm"},{"key":"677_CR325","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/ijms20030779","volume":"20","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Ikegaya Y, Koyama R (2019) The astrocytic cAMP pathway in health and disease. Int J Mol Sci 20:779","journal-title":"Int J Mol Sci"},{"key":"677_CR326","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.5665\/sleep.6030","volume":"39","author":"Y Zhu","year":"2016","unstructured":"Zhu Y et al (2016) Intermittent short sleep results in lasting sleep wake disturbances and degeneration of locus coeruleus and orexinergic neurons. Sleep 39:1601\u20131611","journal-title":"Sleep"},{"key":"677_CR327","doi-asserted-by":"publisher","first-page":"10255","DOI":"10.1523\/JNEUROSCI.0275-18.2018","volume":"38","author":"Y Zhu","year":"2018","unstructured":"Zhu Y et al (2018) Chronic sleep disruption advances the temporal progression of tauopathy in P301S mutant mice. J Neurosci 38:10255\u201310270","journal-title":"J Neurosci"},{"key":"677_CR328","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1111\/febs.14456","volume":"285","author":"R Zorec","year":"2018","unstructured":"Zorec R, Parpura V, Verkhratsky A (2018) Preventing neurodegeneration by adrenergic astroglial excitation. FEBS J 285:3645\u20133656","journal-title":"FEBS J"},{"key":"677_CR329","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/jcbfm.1993.45","volume":"13","author":"MH Zornow","year":"1992","unstructured":"Zornow MH, Maze M, Dyck JB, Shafer SL (1992) Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metabolism 13:350\u2013353","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"677_CR330","first-page":"353","volume":"317","author":"RM Zweig","year":"1989","unstructured":"Zweig RM et al (1989) Neuropathology of aminergic nuclei in Alzheimer\u2019s disease. Prog Clin Biol Res 317:353\u2013365","journal-title":"Prog Clin Biol Res"}],"container-title":["Handbook of Experimental Pharmacology","Adrenoceptors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2023_677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T15:03:51Z","timestamp":1725375831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2023_677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031667756","9783031667763"],"references-count":331,"URL":"https:\/\/doi.org\/10.1007\/164_2023_677","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"27 July 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"AF and MS are co-founders of CuraSen Therapeutics, a company developing adrenergic drugs for the treatment of neurodegenerative disease. All authors own shares of stock in CuraSen Therapeutics. Some of the work presented here was partially supported by the National Institutes of Health (NIH R01 AG054533) awarded to MS.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding Sources\/Conflict of Interest"}}]}}